2012 ASHP Midyear Clinical Meeting Resident Poster Listing

2012 ASHP Midyear Clinical Meeting
Resident Poster Listing
Resident Poster Presenters:
Congratulations! Below is your scheduled poster presentation time and board number. This list is sorted by the
Last Name of the Primary Author —not by presentation time. You may also search the list by using your
Submission ID. If you have trouble locating your poster, please send an email to [email protected].
Allow three business days for a response. Date, time, and board number cannot be changed. ASHP will not edit
titles, abstracts, or presenters. If you wish to withdraw your poster, please contact [email protected]. Be sure to
read the Poster Presenter Handbook located at http://www.ashp.org/Get_Involved for additional instructions.
We’ll see you in Las Vegas!
Educational Services Division
Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Impact of an admitting pharmacist on identification of sepsis in an emergency room setting Comparison of time in therapeutic range of face‐
to‐face patients and telephone patients at a Veterans Affairs pharmacist‐
run anticoagulation clinic Evaluation of clevidipine in blood pressure management in patients with acute hypertension requiring intravenous administration Impact of improving clinical assistants' knowledge on medication history errors 10‐116 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐081 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐200 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐132 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Antibiotic drug‐related problems in chronic hemodialysis inpatients with central line associated blood‐stream infections (CLABSI) 7‐266 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317706 Mina Abdalla FL 316290 Elizabeth Dorothy Ackerman IN 318452 Rebecca Adorable IL 317141 Alejandro Luis Adorno OH 317985 Nasim Aghaienia OK 1 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Treatment associations with recurrent urinary tract infections in a Veterans Affairs Medical Center Adherence to cardiovascular and hypoglycemic agents among visually impaired and non‐impaired Veterans with Diabetes Pharmacist led approach to decrease inappropriate utilization of stress ulcer prophylaxis (SUP) in medical patients Asthma medication education intervention to improve patient understanding and outcome Distribution of common CYP2C19 single nucleotide polymorphisms in Saudi population Evaluating safe and effective dosing of allopurinol in older adults with renal impairment Bleeding outcomes associated with the use of treatment doses of enoxaparin in hospitalized patients on hemodialysis Evaluation of the use of intravenous immune globulin in a large hospital system and assessment of savings with the implementation of a dose rounding protocol Implementation of an internal oral chemotherapy service within an integrated health system Ketogenic diet in the status epilepticus management 8‐247 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐104 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐067 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐240 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐190 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐157 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐289 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐083 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐232 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐213 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 315655 Christine P. Aguilar TX 315541 Tazin R. Aijaz OH 318057 Lesleigh Ailts IA 317949 Rachel Aipperspach WA 316704 Aziza Ajlan Saudi Arabia 318095 Rosemary Akachukwu OH 317699 Samuel O. Akinyele TX 317669 Sonya Akrout NJ 317464 Sanjin Alajbegovic WA 317080 Carolina Alarcon‐
Payer 2 | P a g e Spain Time Submissi
on ID Primary Author Full Name State/ Country 317053 Angel Albacete Ramirez Spain 315979 Nerissa J. Alday OH 317366 Nathaniel Aldrich MO 312918 Elizabeth L. Alford TN 318137 Parijat Ali NJ 317315 Asima N. Ali IN 316666 Ndidi P. Alino UT 315407 Ohoud Aljuhani AZ 315336 Shadi S Al‐
Jureidini MO 316597 Miranda Lane Allen VA 3 | P a g e Title Session/ Board Number Day Time Ertapenem use study as outpatient intramuscularly antibiotic therapy 6‐212 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Evaluation of the use of coagulation factor VIIa (recombinant) in pediatric patients Effects of dexmedetomidine dosing protocol compliance on safety and efficacy outcomes in critically ill patients Comparison of GFR estimation using the Schwartz equation and the Bedside CKiD equation in patients 1 to 12 years old Antipsychotic treatment of delirium in the intensive care unit: a systematic literature review Assessment of factors that influence pharmacy residency applicant selection of a specific post graduate year one (PGY1) program Implementation of pharmacist‐managed transitions of care program at Intermountain Medical Center Effect of dexmedetomidine versus propofol on opioid requirements in mechanically ventilated patients Evaluation of warfarin therapy in an outpatient anticoagulation clinic: a retrospective data review Evaluation of the management of COPD exacerbations in a community teaching hospital 8‐107 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐048 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐186 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐093 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐093 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐235 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐006 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐028 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐249 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Assessment of fluoroquinolone resistance in urinary pathogens and implementation of urinary tract infection treatment guidelines Evaluate effects of vancomycin minimum inhibitory concentration (MIC) on patient outcomes in Methicillin‐susceptible Staphylococcus aureus (MSSA) and Methicillin‐
resistant Staphylococcus aureus (MRSA) bacteremia Sodium polystyrene sulfonate (SPS) evaluation for risk of colonic necrosis and efficacy Venous thromboembolism prophylaxis in traumatic brain injury: does timing of prophylaxis play a role? Bivalirudin utilization in obese patients and the frequency of post procedural bleeding complications in patients undergoing percutaneous coronary intervention for acute coronary syndrome Adverse events associated with intravenous iron infusions at an outpatient infusion center Evaluation of the impact of pharmacy intervention on vancomycin dosing and therapeutic drug monitoring Optimizing use of human albumin for intradialytic hypotension during hemodialysis Implementation of a quality monitoring system in a pharmacist driven anticoagulation management service. 10‐192 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐027 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐095 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐079 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐135 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐188 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐061 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐022 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐123 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318213 Katherine Allen IL 315471 Jonathan Alligood GA 317509 Abdelmajid H. Alnatsheh IN 318155 Anja M. Alpendre MI 316125 Robert M. Alspach PA 318331 Amber Rose Altstadt MN 318451 Sarah Alvey MO 311975 Mehdi Amiri CA 317922 Robert V. Andersen NE 4 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Comparing the rates of hemoglobin A1c goal achievement between diabetic patients monitored in a clinical pharmacist managed clinic to those in a primary care clinic Retrospective Evaluation of Gentamicin Dosing Protocol Based on Gestational Age 7‐164 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐055 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐103 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐190 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐218 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐101 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐248 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐034 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐136 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315648 Morgan C. Anderson NY 315362 Michelle M. Andrade NH 318488 Allen Antworth IN 318639 Bernadette Aragon 317454 Paula Arcenillas 316632 Nicole A. Ard OR 318054 Oluwatoyin A Arije LA 316578 Avo Arikian CA 318497 Kenny R. Aristide FL 5 | P a g e MN Spain Evaluation of pharmacy student self‐perception of weight and relationship to comfort in lifestyle modification counseling Evaluation of magnesium replacement products in patients with hypomagnesemia Description of oncological‐
hematological clinical trials and the participation of a Spanish pharmacy department (PhD) in cancer advances. Evaluation of Pain and Palliative Care Education in US Pharmacy Schools Retrospective analysis of effects of serum albumin on vancomycin trough levels in type 2 diabetes mellitus Expansion of pharmacy‐
managed intravenous (IV)‐
to‐oral (PO) conversion to include antiepileptic drugs (AEDs) Development and implementation of a pharmacist‐driven medication therapy management service at an outpatient heart failure clinic Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 316096 Marjohn Armoon FL 6‐018 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318358 Matthew E. Arnold IA 9‐068 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 315779 Corinne Davies Asakevich OK 7‐256 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317213 Noha Ashy MA 9‐138 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 314188 Bassam Atallah VA Effectiveness of compounded bioidentical hormone replacement therapy (BHRT) in reducing vasomotor symptoms in menopausal women: a prospective observational study Impact of pharmacist medication reconciliation in conjunction with outpatient physician follow‐up visits after hospital discharge Evaluation of a pharmacy pneumonia discharge service on hospital readmission rates Assessing the clinical significance of melatonin and warfarin potential drug interaction Appropriateness of ticagrelor utilization in a 445 bed community hospital 6‐242 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317855 Tim Atkinson NY 7‐224 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318260 Uzoamaka E. Atuegwu NY 7‐238 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315376 Kathryn Augustin WI 6‐260 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317873 Nadia I. Awad NJ 6‐089 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317194 Joy A. Awoniyi FL 10‐106 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6 | P a g e Incidence of Clostridium difficile after treatment with antibiotics for community acquired pneumonia (CAP) Evaluating the use of white cell stimulating factors for primary prevention of febrile neutropenia in a tertiary health care system Impact of measuring serum procalcitonin levels on duration of antimicrobial therapy in critical care patients with suspected pneumonia Protocol failures in Acetadote (acetylcysteine for injection) therapy for acetaminophen toxicity Impact of a pharmacy‐
derived nursing education program on medications administered to patients on enteral feeding tubes or Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Readmission rates after angiotensin converting enzyme inhibitor or angiotensin receptor blocker discontinuation in patients with heart failure and acute kidney injury EVALUATION OF A PHARMACY DRIVEN CONCIERGE SERVICE FOR HEART FAILURE PATIENTS Therapeutic de‐escalation of daptomycin in osteoarticular infection 10‐241 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐177 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐216 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Optimization of currently employed technologies used in the dispensing of discharge medications at the Miami VA Healthcare System Analysis of antibiotic use in staphylococcus aureus bacteremia 10‐099 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐128 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. with dysphagia 315556 Katherine Aymond LA 316245 Rejena Azad SC 317444 Pilar Aznarte Spain 316860 Nicholas R. Bacon FL 315538 Elizabeth A. Badgley PA 315103 Stephanie Ann Baer IN Evaluation of preceptor development needs at a community hospital 9‐072 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317881 Leslie S. Bahadori CT 10‐043 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318482 Stacey Bailey IN 9‐102 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316032 Abby M. Bailey KY Analysis of opioid‐related adverse drug events (ADEs) in order to drive medication safety efforts: a retrospective chart review Rapid cycle process improvement of the admission medication reconciliation process following implementation of CPOE in a large health system Pilot survey of naloxone dispensing as an opioid overdose prevention strategy 10‐214 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Implementation of a medication therapy management (MTM) service as part of an employer‐
sponsored diabetes management program for health plan beneficiaries Efficacy and tolerability of hyaluronate derivatives in outpatients at a Veterans Affairs hospital Assessment of outcomes in high risk veterans with hyperlipidemia: A retrospective study of the impact of a pharmacist‐run chronic disease management clinic Medication use evaluation of dabigatran in a multi‐
hospital system 9‐078 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐167 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐105 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐088 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐220 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐146 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐020 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐109 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐257 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316195 Katie M. Balko IN 315794 Jeffrey Balsam NY 314679 Christina Banks KS 316461 Violeta Barac FL 317864 Catalina Barcelo Spain 312718 Meghan Barclay NY 317414 Maxime Bareau France 318432 Leslie Mizelle Barefoot NC 318198 Alex Barker VA 8 | P a g e Influence of chronic hepatitis b or c and liver fibrosis stage on plasma levels of efavirenz (EFV) in human immunodeficiency virus (HIV) patients Development of a methadone wean protocol in the neonatal intensive care unit at University of Rochester Medical Center Hydrocortisone replacement therapy in adrenal insufficiency: assessment of the patients' knowledge. Implementation of decentralized pharmacy services in a rural community hospital: six months later Assessing the effect of a pharmacist intervention in the management of diabetes and screening for depression of patients residing in central Appalachia Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 317457 Mia N. Barnes DC Impact of antiretroviral therapy utilization in the intensive care unit 8‐010 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317889 Kelli D. Barnes OH 8‐144 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318052 Nicole L. Baron NY 7‐233 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316726 Shayla Barraclough CO 10‐011 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316507 Andrea Barton TX Pharmacist use of an electronic medical record to improve medication use in patients with chronic kidney disease in a patient centered medical home Delayed use of thrombolytic therapy in massive pulmonary embolism: case report Implementation of a pharmacy intervention to reduce inappropriate usage of stress ulcer prophylaxis among the hospitalist team at a community hospital Propranolol therapy in the management of infants with supraventricular tachycardia 8‐256 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317390 Rachel Basinger TX 8‐284 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316062 Lindsey C. Bates FL 10‐073 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318177 Keri Lynn Bazzell KY 10‐237 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318478 Lonzie Beamon LA 10‐249 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317977 Rachel S. Beaty AL 9‐014 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9 | P a g e Association between anticholinergic burden and hospital length of stay in older adults Dabigatran prescribing criteria and adverse events: medication utilization evaluation Clinical cure rates as affected by minimum inhibitory concentration and antimicrobial selection of vancomycin or linezolid in methicillin resistant staphylococcus aureus pneumonia Analysis of patient‐specific factors that contribute to the development of contrast‐induced nephropathy Medication reconciliation in an outpatient surgical area in comparison to the current inpatient system, a quality Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Therapeutic enoxaparin in the hospitalized patient: assessing drawn anti‐Xa levels to determine the benefits of pharmacist management when compared to provider management Development of clinical pharmacogenetic competencies 9‐208 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐203 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Effect of a transition of care clinic interdisciplinary intervention on quality of heart failure transition of care Evaluation of primary care provider pharmacist run shared medical appointments for patients with diabetes Predictors of therapeutic argatroban dosing requirements in critically ill patients Predictors of antipsychotic polypharmacy in an acute‐
care teaching hospital 7‐071 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐024 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐156 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐158 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Evaluation of antiretroviral (ARV) and prophylactic antimicrobial prescribing for HIV‐infected hospitalized patients and the impact of clinical pharmacist interventions Pharmacist initiative to optimize antiretroviral therapy (ART) in human immunodeficiency virus (HIV) patients during hospitalization and at transitions of care 9‐142 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐151 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. assurance project 316292 Lisa Becker SD 316473 Gillian C. Bell TN 316060 Johanne Bennett NC 313002 Reisel Berger CA 317090 Shaina Bernard PA 318139 Deanna Bice OH 317673 Monique R. Bidell MA 315809 Andrea Bidlencik 10 | P a g e IL Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Comparison of Clinical Outcomes of Ceftriaxone 1 gram daily versus 2 gram daily dosing: Retrospective review of post operative intravenous acetaminophen use 6‐270 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐119 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316527 Margaret Bierman WI 314179 James D. Bird NE 318438 Patrick John Birney TX Decreasing missing dose requests following transitions in care 8‐302 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315262 Amanda Bishop WA 9‐216 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318145 Leslie Bittner OH 8‐159 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316745 Eleanor P. Bituin FL 10‐094 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315683 Angela N. Blaalid MN 9‐171 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317833 Katie M. Blackbourn KS 9‐115 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316613 Michael Trent Blacketer TN 8‐208 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315472 Jacob Blackham UT Influencing state‐wide pharmacy practice with the pharmacy practice model initiative (PPMI) Risk of cardiovascular events with testosterone treatment in men with low testosterone Evaluation of proton pump inhibitor (PPI) use outside of critical care in a community hospital Assessment of controlled substance wasting practices: improving work flow, preventing diversion and reducing environmental exposure to pharmaceuticals Comparison of clarification rates for home medication lists: newly implemented electronic pharmacy technician generated lists compared to hand‐written nursing lists Pharmacoeconomic evaluation of rivaroxaban vs. enoxaparin for VTE prevention in total hip and knee arthroplasty patients The clinical and financial impact of implementing a medication assistance voucher program under the 340B drug pricing program 6‐229 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 11 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Comprehensive medication management: impact of a pharmacist provided service among patients with mental illness at an outpatient behavioral health center Evaluating the utility of pharmacy services in a bariatric surgery weight loss center at a community hospital Implementation of a chronic obstructive pulmonary disease (COPD) order set at a Veterans Affairs (VA) hospital Dexmedetomidine: an emerging therapy in alcohol withdrawal syndrome 8‐089 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐007 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐031 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐103 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐024 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐271 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐085 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐165 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317283 Michelle Blair MT 317199 Melonie L. Blake DC 316350 Meredith J. Blalock GA 318007 Haley H. Blalock NC 316162 Lisa Blanchette CT 317123 John Blee TX 318441 Michael E. Bloome MI 316480 Gabriella E. Blyumin IL 12 | P a g e Diagnostic predictive value of the clinical pulmonary infection score (CPIS) versus Hartford Hospital's two plus two system for identifying patients with suspected ventilator‐associated pneumonia (VAP) Multi‐dose medication dispensing at discharge: effects on compliance, readmissions, and cost in patients with chronic obstructive pulmonary disease The FDA recommends it, so what? Are we dosing epoetin alfa correctly in chronic kidney disease (CKD) patients according to the FDA? Evaluation of postnatal dexamethasone use for respiratory support in infants less than one year old Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 316451 Megan N. Bodge WV 9‐263 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 312696 Amanda L. Boese WI 6‐258 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 314493 Christine Claire Boffing NV 9‐191 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317330 Genevieve C. Bohmfalk TX 8‐279 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316861 Kristin Bohnenberger PA 6‐151 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318257 Dayla M. Boldt NE 7‐124 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315649 Christa Bordeaux NY 7‐165 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316823 Matthew Borden MA 9‐133 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316475 Jason Boswell TN Utilization Rates and Methods of VTE Prophylaxis in Medical Oncology and Hematopoietic Cell Transplant Inpatients at an Academic Medical Center Value of pharmacist‐
provided medication therapy management services for patients enrolled in a patient‐
centered medical home program Pharmacist managed care of diabetes, hypertension and hyperlipidemia within patient aligned care teams (PACT) Impact of carbapenem restriction and other measures on hospital antibiotic use and susceptibility patterns National trend in modafinil overexposures over a ten‐
year period: a retrospective review Evaluation of physician adherence to published guidelines for the treatment of urinary tract infection and skin and soft tissue infection based on piperacillin/tazobactam use Incidence of Clostridium difficile infection in patients receiving proton pump inhibitor therapy Bridging with half‐
therapeutic dose enoxaparin therapy in outpatients with ventricular assist devices: a quality assurance initiative Anticholinergic use with antipsychotic medications within a state inpatient psychiatric institute 8‐204 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 13 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Reassessing bleeding risk vs. stroke prevention benefit for warfarin therapy in veterans who have atrial fibrillation Improving clinical quality measures for venous thromboembolism in a community hospital Prothrombin complex concentrate (PCC) is safe as an adjunct to control excessive surgical bleeding in cardiovascular surgery: ventricular assist device (VAD) insertion Infection Control Associated with Automated Dispensing Cabinets 7‐118 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐164 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐030 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐058 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐059 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐156 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐236 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐046 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐186 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐056 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 312444 Kathryn A. Bowers NE 316296 Kendra J Bowling IL 316209 Chad Bradford CA 314629 Megan Brafford FL 318179 Rebecca L. Bragg MO 315160 Kelly Braham NY 316699 Jason J. Braithwaite UT 316383 Adam Brancaccio MI 318211 Rachel A. Branstad MN 318016 Whitney M. Bray MO 14 | P a g e Evaluation of the impact of a pharmacist provided chronic opioid management education program to physicians in a primary care practice setting Evaluation of the Antifactor Xa Assay versus Activated Partial Thromboplastin Time in the Management of IV Heparin in a Veteran Population Evaluation of outpatient pharmacist workload using objective and subjective measures Appropriateness of Phenytoin Loading Doses Given in the Emergency Department Chromogenic factor ten (CFX) assay in patients using warfarin: evaluation of turnaround time and incidence of adverse events Characterization of CMV‐
IGIV use for various indications within a pediatric academic Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Effectiveness of a potassium and magnesium replacement in patients after coronary artery bypass grafting (CABG) surgery Impact of pharmacist‐led interventions on reducing heart failure exacerbations 9‐180 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐102 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Economic evaluation of invasive treatments for palmar hyperhidrosis 6‐205 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Enhancing antimicrobial prescribing through monitoring of procalcitonin levels Evaluation of the admission medication reconciliation process using a time‐motion study Journey from development through implementation of extended‐infusion piperacillin‐tazobactam Pharmacist‐managed latent tuberculosis clinic: a retrospective analysis to identify process improvements Implementation of a transition clinic for heart failure patients and the impact on 30‐day readmission rates Impact of pharmacist antibiotic therapy recommendations in patients hospitalized with community acquired pneumonia (CAP) following culture and serology results. Daptomycin use at a large academic medical center 7‐101 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐066 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐183 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐050 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐125 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐214 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐236 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. institution 317204 Elizabeth A. Brenner MN 315352 Stephanie Brey OH 316901 Maria Teresa Brieva Herrero Spain 318002 Brittany Bronemann NC 317721 Mackenzie Brown IA 317849 Laura Brown MN 318408 Andrew J. Brown CT 316791 Cynthia A. Brucato OH 318144 Reina A. Bruinsma SD 318129 Erica Brumer NY 15 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Impact of penicillin allergy skin testing on antibiotic selection in a tertiary hospital Effect of continuous infusion antihypertensive therapy compared to intermittent antihypertensive administration on the time to goal blood pressure in patients presenting to the emergency department with acute stroke Evaluation of propofol versus dexmedetomidine in the intensive care unit (ICU) for mechanically ventilated patients Vancomycin dosing requirements in pediatric patients with empyema, pleural effusion, and/or lung abscess Antibiotic utilization prior to the implementation of peptide nucleic acid fluorescence in situ hybridization (PNA FISH) test for identifying possible coagulase‐negative staphylococci blood culture contaminants Evaluation of the use of iodinated intravascular contrast media agents at a tertiary care hospital Impact of student pharmacists' contribution to a medication reconciliation process in an academic, family medicine based patient centered medical home (PCMH) Alemtuzumab infusion reactions in stem cell transplant: risk factors and clinical impact 7‐116 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐153 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐235 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐237 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐283 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐078 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐268 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐194 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317124 Jessica Bubel ND 314488 Mason Bucklin NY 314302 Nhi T. Bui TX 315240 Christopher V. Bui TX 317387 Michael Bui TX 316272 Phuoc Bui FL 318112 Christina F. Bulkley OK 318295 Cara Burditt IL 16 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 318127 Shamama Burney OK Appropriateness of acid suppression therapy in a community hospital 7‐269 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315596 Megan R. Burns IN Analysis of dabigatran use in hospitalized patients 9‐073 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318253 Ashley M. Burress WA 9‐245 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318028 Ryan Guynn Burt ID 6‐044 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317222 Kellie Buschor OH 8‐133 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317972 Taylor W. Butler TN 8‐221 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316122 Jared Butler IN 9‐076 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318082 Marion Buyse Improving pharmacy anticoagulation in a health clinic on the Tulalip Indian Reservation. Development and implementation of an emergency department pharmacist service in a rural based medical center Effect of optimal medication therapy on hospital readmission in chronic heart failure Developing an evaluation and reference guide for appropriate clinical use of granulocyte colony‐
stimulating factors (G‐CSF) Development of a standardized process to analyze data and improve smart pump medication libraries Is pharmacist presence in the clinical unit really necessary? 6‐024 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 312856 Richard Caballero CA 9‐023 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318352 Elisabeth Anne Caddell OR 6‐107 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316864 John C. Cadwalader PA 6‐152 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 17 | P a g e France Impact of a recapture intervention to increase pharmacy prescription volume at a military treatment facility pharmacy Analysis of an intensive care unit (ICU) extended‐infusion piperacillin‐tazobactam protocol Comparison of vancomycin pharmacokinetics in spinal cord injury patients versus non spinal cord injury patients. Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 318021 Shuntao Cai AK Rituximab Rapid Infusion and Infusion Reaction 6‐004 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317954 Lauren Camaione NY Pharmacokinetic model of vancomycin in pediatric patients 7‐231 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317587 Jacqueline R. Campbell AZ 6‐013 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317448 Nicholas Campbell PA Implementation of a multidisciplinary asthma management clinic and asthma awareness program in a rural American Indian medical center Assessment of the use of micafungin at a teaching institution 6‐164 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317981 Marisa Canadas Garre Spain 6‐223 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318321 Krystal Canally OH 8‐169 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316706 Barbara Cancela‐
Diez Spain 6‐201 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318275 Chad W. Cannon FL 10‐132 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316790 Amanda Cantin CT 10‐038 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317430 Maria de la Salud Caparros Therapeutic alternatives in the treatment of metastatic melanoma based on drug labels Implementation of discharge medication reconciliation and education by pharmacists Secondary cutaneous toxicity to erlotinib in advanced non small cell lung cancer Comparison of intravenous tobramycin dosing methods using the area under concentration curve vs. trough monitoring in adult cystic fibrosis patients Pharmacy residency program integration between a community hospital and an academic medical center: days one to one hundred Comparative study of the effectiveness of tyrosine‐
kinase inhibitors versus traditional chemotherapy regimens in non‐small lung cancer 6‐215 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 18 | P a g e Spain Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 318523 Catherine Marie Cappetto OH 8‐171 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318140 Blake J. Carley WI Effect of integrated pharmacy services on an outpatient family medicine center: determination of pharmacy recommendation approval rate and physicians' perceptions of integrated pharmacy services Describing the integration of pharmacy informatics into the medication use process 6‐284 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 314296 Rachael L. Carloni FL 10‐057 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 314083 Jenna M Carmichael PA 6‐114 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317883 Kimberly A. Carnegie IN 9‐096 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 315775 Jasmine Carpenter DC 8‐002 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315547 Nicholas Carris TN Heparin dosing for the treatment of venous thromboembolism in overweight, obese, and morbidly obese patients Implementing a Pharmacist‐
Run Oral Chemotherapy Medication Therapy Management Clinic in an Outpatient Hematology/Oncology Clinic Implementation of dedicated pharmacy services in the emergency department at a level two trauma center Evaluation of emergency hospital visits and mortality in patients taking high dose opioids for nonmalignant pain at the Washington, DC Veterans Affairs Medical Center Evaluation of meropenem use in critical care units at a community hospital 8‐197 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316642 Kacey A. Carroll IN Assessment of empiric antibiotic use in patients with a penicillin, cephalosporin, or carbapenem allergy in a community hospital setting 9‐088 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 19 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Evaluation of the use of dexmedetomidine in critically ill patients in the cardiovascular intensive care unit Medication Discrepancies in the Neonatal Nurseries: A Retrospective Analysis of Medication Discrepancies between NeoData Database and the Patients eMAR Impact of Introduction and Education of a Validated Pain Scoring Tool in a Level III Neonatal Intensive Care Unit Evaluation of the efficacy of the adult intensive care and medical/surgical potassium replacement protocols in a community hospital system Implementation of a standardized empiric antibiotic guideline for the management of sepsis in the emergency department: a single center, before and after study Assessment of appropriate use of empiric vancomycin in patients admitted to the medical intensive care unit (MICU) with community‐
acquired pneumonia Follow‐up of emergency department culture results by a pharmacist compared to nursing Antiemetic use in chemotherapy induced nausea and vomiting 10‐130 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐110 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐191 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐092 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐030 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐049 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐199 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐276 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Discontinuation of premedications in patients tolerating paclitaxel 8‐251 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318242 Micaela Carroll FL 316616 Laura Carson KS 315002 Josh Carter TN 317117 Jamalyn Casey IN 316124 Jeremy D. Casper GA 316731 Michelle Cefaretti MI 318418 Brandy Ceril NV 317071 Phueng Cha WI 316057 April L Chamberland‐
Tremblay TX 20 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 315033 Esther Chamorro de Vega Spain 6‐195 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316443 Izabela A. Chamot OR 6‐100 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318560 Ruth Chan TN 8‐228 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316629 Sean Chantarapanont IL EFFECTIVENESS OF POSACONAZOLE PROPHYLAXIS IN PATIENTS SUFFERING FROM HAEMATOLOGICAL MALIGNANCIES Evaluating bisphosphonate initiation rates post fragility fracture at a Veterans Community Living Center and Comprehensive Rehabilitation Unit (CLC) and its impact on Veteran bone health Stress ulcer prophylaxis and C. difficile risk: a comparison of proton pump inhibitors and H2‐receptor antagonists In‐house inventory: lessons learned 10‐167 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318353 Sayree Ronnie Chanvitayapongs KS 9‐121 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317229 Stephanie Christine Chase KY 10‐229 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318336 Ying Yin Chen MD 7‐020 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315805 Heidi Chen IN 9‐074 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316624 Gloria Cheng CA 9‐037 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 21 | P a g e Comparison of levofloxacin versus azithromycin and ceftriaxone for the treatment of community acquired pneumonia in a large community hospital Comparison of carboplatin tolerability between different methods of estimating creatinine clearance Evaluating the incidence of gastrointestinal bleeding from oral antiplatelet and anticoagulant agents in a community teaching hospital setting Effects of a pharmacist‐run medication management service on the quality of life of patients with heart failure in the ambulatory care setting: a pilot study Retrospective study to assess the impact of pharmacist driven interventions in improving Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 8‐146 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐014 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐117 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐143 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐168 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐095 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐150 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐194 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐105 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. patients perception of pain management 317917 Emma E. Chermely OH 317268 Stephen C. Cheung CO 315246 Poonam Chhunchha PA 315571 Thomas D. Chiampas IL 315798 Justin J. Chiang NY 312972 Lindsey N. Childress OR 317982 Larry J. Childs OH 315412 Chih Chin TN 318236 Megan Ching OR 22 | P a g e Implementation and evaluation of pharmacist led medication therapy management services in primary care physician offices Antimicrobial stewardship program: implementation of a pharmacy driven urinary tract infection protocol Analysis of vancomycin prescribing patterns and therapeutic drug monitoring at an academic medical center Evaluation of the occurrence of antiretroviral and opportunistic prophylaxis errors within the inpatient setting Efficacy of rasburicase single, low dose compared to weight‐based multi‐dose regimens in patients at risk for tumor lysis syndrome Effectiveness of the pharmacist intervention on hypertension, hyperlipidemia, and diabetes mellitus in the Native American population The design and implementation of a pharmacist‐driven medication reconciliation process Adverse events related to patient‐controlled analgesia (PCA) in a large healthcare service provider Evaluating a proactive panel support (ProPS) pharmacy program in an integrated health care system Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Comparison of the comprehension of diabetic patients who are provided with education in a clinical pharmacist managed clinic versus a non clinical pharmacist managed clinic Evaluation of a pain and sedation protocol in a mixed surgical/medical intensive care unit Retrospective comparison of dabigatran etexilate versus warfarin on hospital length of stay in patients with new‐
onset atrial fibrillation Evaluating the impact of basal plus insulin order set on inpatient glycemic control Evaluation of risk factors for the development of amiodarone infusion site reactions: a retrospective cohort analysis Evaluation of adherence to the Centers for Medicare and Medicaid Services pneumonia core measure pre‐ and post‐ computerized physician order entry implementation and its clinical outcomes Managing postoperative glycemic control in cardiac surgery patients with evidence‐based electronic order sets Comparison of pharmacist versus usual medical care prescribing habits for periprocedural bridging with enoxaparin Low‐Dose Ketamine Infusion in Adult Patients with Sickle Cell Disease ‐ Impact on Management of Acute Painful Episodes 7‐163 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐247 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐082 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐092 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐109 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐007 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐039 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐071 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐141 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315646 Elizabeth Choi NY 318496 Andrew B. Choma NY 317656 Beverly J. Chorbak NJ 316634 Nitha K. Chou FL 316605 Ashlen E. Christie KS 316428 Juliane Christina AZ 316728 Michelle Chu CA 314626 Maegan A. Chu IN 315360 Aileen Chu IL 23 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Pharmacists Impact on Frequency of Hospitalization and Emergency Department Admissions Evaluation of fidaxomicin use in a large medical center 8‐240 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐188 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. Compliance with daily sedation holidays and chlorhexidine mouthcare as part of a ventilator‐
associated pneumonia prevention strategy in an intensive care unit at a community hospital Assessment of adherence to antibiotic prophylaxis guidelines for all procedure types in a large academic teaching hospital Implementation of a basal bolus insulin protocol for glycemic control in post‐
spinal surgery patients: detemir versus glargine. Use of an interactive game to increase awareness of appropriate antibiotic use in community‐dwelling older adults Effectiveness and safety of intraventricular nicardipine for the treatment of refractory vasospasm due to nontraumatic subarachnoid hemorrhage Development of a peri‐
operative, multi‐modal pain management intervention for orthopedic surgery patients Assessment of a multidisciplinary heart failure transition team 7‐003 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐215 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐183 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐024 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐220 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐049 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐061 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315371 Nancy Chung TX 316485 Christine Ciaramella NY 315325 Nina M. Cimino MD 317515 Frank Cirrone NY 317961 Cassandra Clement IL 318544 Kalin M. Clifford MD 315992 Kristina D. Clyburn WA 318450 Lisa Co CA 315306 Christina B. Coakley FL 24 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Evaluation of tranexamic acid administration on transfusion requirements in an ACS certified level two trauma center Impact on prescribing habits to increase statin use in members with coronary artery disease following a prescriber letter campaign Evaluation of the association between histamine‐2 receptor blockers and/or proton pump inhibitors and the development of late onset sepsis in a neonatal intensive care unit Evaluation of bivalirudin use for the management of heparin‐induced thrombocytopenia at a large academic medical center Evaluation of potentially inappropriate medication use for insomnia in non‐
hospice hospitalized older adult patients Characteristics of Native Americans with HIV and implications for care 7‐270 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐113 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐200 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐042 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐040 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐255 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318133 Alex M. Cobb OK 317597 Andrew M. Coelho FL 316009 Hailey K. Collier TN 317568 Megan Colwell CT 316024 Elizabeth A. Conger MI 315319 Christina Connel OK 318151 Kelly Connelly MA Rasburicase utilization in an ambulatory care cancer center 9‐154 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317281 Whitney A. Conroy NM 7‐135 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317460 Daniel Contreras TX Implementing a pharmacist‐
managed cardiovascular risk reduction clinic for patients with type 2 diabetes at Gallup Indian Medical Center Implementation of a protocol for extended infusion beta‐lactam antibiotics in a pediatric hospital 8‐286 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 25 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 317143 Ryan Costantino MD Evaluation of stress ulcer prophylaxis in adult critically ill medical patients 7‐010 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316164 Jesus Cotrina Luque Spain 6‐199 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318259 Jordan Counts OH 8‐164 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316836 Catharina Cramer MI Development and dissemination of a high‐risk pediatric medication guideline in a tertiary hospital Evaluating the Effectiveness and Satisfaction with Bedside Discharge Counseling and Medication Delivery Evaluation of appropriate lorazepam use for alcohol withdrawal 8‐050 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317331 Angela L. Crispo TX 8‐280 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316349 Christina C. Croft KY 10‐216 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 311190 Bethany S. Cross TX 8‐232 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317801 Joe E. Cruz NJ 6‐085 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316073 Francisca Cuenca 6‐198 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318551 Alfred J. Custer 7‐249 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 26 | P a g e Spain NY Comparison of Outcomes with Continuous Sedative Infusions for the Treatment of Severe Alcohol Withdrawal: Dexmedetomidine versus Benzodiazepines Development of a rural community pharmacist led diabetes management program High‐Dose Oral Medroxyprogesterone for Inappropriate Hypersexuality in Elderly Men: A Case Series Anemia management in the outpatient hemodialysis setting using a revised epoetin alfa administration protocol Suitability analysis of the use of immunoglobulin not registered in the approved technical specifications Evaluation of the effect of post‐discharge pharmacist‐
led patient counseling on 30‐day readmission rates of heart failure patients in the Medicare population Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Extended interval intravenous (IV) tobramycin in young children with cystic fibrosis (CF) Assessment of appropriate approval of non‐formulary requests 10‐016 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐083 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318278 Patricia Cutting CO 316404 Ellen Cvejanovich FL 318024 Emily Czeck PA Atypical antipsychotics for the treatment of delirium 6‐287 Wednesday, December 5 8:30 a.m. – 9:30 a.m. 316788 Jessica Dabady FL 10‐095 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318405 Carly D'Agostino IL 10‐199 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315692 Jaela Dahl FL 10‐067 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318087 Amanda Grant Dalrymple IN 9‐099 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317574 Shawn Dalton SD 9‐211 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316425 Kayleen Daly NC 7‐084 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317679 Justina M. Damiani MI Impact of pharmacists on the management of antimicrobial prophylaxis for surgery Efficacy of more frequent medication batch label runs in reducing missing dose requests Impact of dexmedetomidine on early extubation following cardiac surgery in a veteran population: a retrospective analysis Assessment of the impact of switching insulin delivery methods from vials to pen devices in a veteran population Identification and reduction of high‐dose opioid use for chronic non‐cancer pain through implementation of an opioid surveillance program within a rural VA Health Care System Evaluation and assessment of strategies to improve reimbursement for the treatment of colorectal cancer at a community cancer center Optimal timing of anti‐factor Xa concentrations monitoring in pediatric patients receiving enoxaparin 8‐070 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 27 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 316000 Yen Dang PA Good literacy to enhance response in diabetics 6‐134 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 315693 Kimberlyn M. Dang MI 8‐032 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316243 Linh Dang CT 10‐027 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316342 Matt Daniel NC 7‐080 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316525 Jeremy Daniel KY 10‐222 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317672 Olivia Dansby AL Pharmacy technician medication historian program in the emergency department Concomitant utilization of long acting injectable antipsychotics with oral antipsychotics among patients Implementation of computerized physician order entry system dose‐
range checking at Rex Hospital Mental health resource utilization in patients with post traumatic stress disorder: do benzodiazepines play a role? Facility specific treatment guidelines for common infections 9‐011 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317514 Amy L. Dao KS 9‐113 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316990 Leanna K. Darland WV 9‐265 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316537 Barrett Andrew Darley GA 6‐032 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 312655 Jena Diane D'Ascenzo PA 6‐113 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317658 Johanne Daupin 6‐022 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 28 | P a g e France Effectiveness of the revised orthopaedic warfarin dosing nomogram at Via Christi Hospitals Wichita, Inc. Retrospective evaluation of dornase alfa use in patients without cystic fibrosis in a pediatric intensive care unit Evaluation of empiric treatment of febrile neutropenia in adult cancer patients Potential interaction between melatonin and warfarin: is it worth losing sleep over? Impact of information and the use of a new prefilled prescription form to improve the good use of carbapenems in a french geriatric hospital group Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 318180 Ashley K. Davich‐
Reynolds WI 6‐285 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316034 Marie L. Davies NC 7‐070 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317415 Adamma Davis GA 6‐038 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318322 Christopher Davis MS 6‐054 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317575 Lauren Nicole Davis NC 7‐095 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318017 Lauren E. Davis NM Collaborative practice agreement in establishing a pharmacist‐prescribed sexually transmitted disease (STD) protocol in the emergency department (ED) Predictors of glycemic control among human immunodeficiency virus (HIV) positive veterans with diabetes Utilization of a multidisciplinary team to reduce the rate of hospital readmissions in targeted disease states in a community teaching hospital Effect of bupivacaine liposome on overall post‐
operative opioid usage and hospital length of stay following laparoscopic cholecystectomy, vertical sleeve gastrectomy, and lap‐
band placement procedures. Evaluation of appropriate use of dabigatran and rivaroxaban at a VA medical center Intensive diabetes care and education to improve patient outcomes 7‐138 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316285 Justin C. Davis FL 10‐079 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316216 Meghan Dawes NC 7‐075 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316374 Gaelle de Barry France 6‐019 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 29 | P a g e Incidence of androgen deficiency in patients receiving long‐term opioids for the treatment of chronic non‐cancer pain Impact of pharmacist provided transition of care discharge counseling for high risk medicaid patients Immunoglobulins treatment of pediatric myocarditis Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Efficacy of abatacept in patients with spondyloarthritis refractory to tumor necrosis factor alpha inhibition Reliability of a modified questionnaire Medication Approprianetess Index in a population of patients with multiple chronic conditions Adequacy of thromboembolic prophylaxis prescribed in an emergency department Influence of quality improvement processes on the venous thromboembolism (VTE) subgroup of the PIVOT Collaborative Comparison of calcium and phosphorus dosing between individualized and standardized parenteral nutrition in preterm neonates Vancomycin loading doses in the emergency department (ED) of a large community hospital: assessing adherence and clinical outcomes of new loading dose recommendations Evaluation of rivaroxaban use following joint replacement surgery at a community hospital Analysis of biochemical data and the occurrence of fractures in the dialysis population Pneumonia readmissions: a retrospective review to assess risk factors and to decrease 30‐day readmission rates 6‐197 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐193 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐194 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐091 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐226 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐273 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐178 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐113 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐202 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315433 Soraya De la Fuente Ruiz Spain 314517 Laura de la Higuera Vila Spain 315004 Ana de Lorenzo‐
Pinto Spain 316604 Jaclyn DeCrosta FL 318334 Jamie L. Deeds TN 316058 Scott Dietrich NC 317990 Samantha A. Delibert PA 315518 Allan Demuth ND 316916 Elena Denisko NY 30 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Evaluation of prescribing and monitoring practices for adult inpatients receiving filgrastim in a community teaching hospital Use of antibiotics in patients with acute COPD exacerbation: is there a benefit associated with this practice? Evaluation of hypoglycemic episodes in the intensive care unit (ICU) 7‐243 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐229 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐165 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐268 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐208 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐056 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐135 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐253 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐127 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐153 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318379 Ashleigh M. Dennis NY 318590 Latasha L. Dennis TN 317449 Armisha Desai PA 317063 Avani Desai TX 315463 Khyati Desai KY 315581 Christopher Devine NH 316976 Adam Diamond MA 318600 Andrea Dickens WA 315792 Aimee Dietle MA 318147 Amanda Dietzek MA 31 | P a g e Evaluation of an innovation tool for an inpatient pharmacy in a 580 bed veterans affairs hospital Description of a novel drug shortage plan to manage intravenous levofloxacin shortage at a large community healthcare system Assessment of student pharmacist knowledge regarding the use of media to influence prescription medication use and misuse Incidence of medication‐
associated admissions to a medical intensive care unit Evaluating the role of voriconazole therapeutic drug monitoring for the treatment of invasive aspergillosis in the acute myeloid leukemia (AML) patient population Impact of clinical pharmacy services in uncontrolled diabetic patients at a federally qualified health center. Novel immunotherapy: the utilization of sipuleucel‐T in metastatic prostate cancer Time Submissi
on ID Primary Author Full Name State/ Country 317583 Katherine Dillinger NC 317836 Abbey DiMarco KY 317644 Sara Dingwall FL 316985 David Dinh VA 317520 Jennifer Hope Dixon MN 318657 Jimmy H. Do TX 317010 Katherine Haney Dollar GA 316966 Elza Aparecida Machado Domingues Spain 317980 Danielle Donzal IL 316219 Christopher F. Dooley CT 32 | P a g e Title Impact of an intravenous gentamicin dosing policy change in a neonatal intensive care unit Assessment of health outcomes from a VA initiated proton pump inhibitor conversion Outcomes of daily medication education in patients hospitalized for congestive heart failure Medication use evaluation of dexmedetomidine in a community hospital setting Development and evaluation of a medication reconciliation process conducted by pharmacy interns Melatonin use and the incidence of oral candidiasis (thrush) in brain injured patients within a rehabilitation setting Development and implementation of a decentralized pharmacist practice model in a community hospital Antiretroviral therapy and cardiovascular risk in older patients Evaluating the safety and efficacy of a heparin protocol for the treatment of venous thromboembolism (VTE) in the morbidly obese Comparison of the efficacy and safety of low‐molecular‐
weight heparins for venous thromboembolism prophylaxis in medically ill patients Session/ Board Number Day Time 7‐096 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐233 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐114 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐250 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐181 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐312 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐035 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐207 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐184 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐026 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 315207 Sarah Doornbos SC Tranexamic Acid and Massive Transfusion 8‐174 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318271 Ashley M. Dorward PA 6‐186 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317356 Alyssa A. Douville IL 10‐178 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315799 Jessica M. Downes OK 7‐257 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316384 Jana Downing TX 8‐315 Wednesday, December 5 11:30 a.m. – 12:30 p.m. 316476 Kelli Dozier DC 8‐004 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316459 Erica L. Dranko DE 8‐020 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317858 Bryson M. Duhon TX 8‐292 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315994 Lisa E. Dumkow MI Evaluating the impact of a pharmacist led heart failure clinic on decreasing hospital readmissions Evaluation of a comfort care order set in the medical intensive care unit at an academic medical center Evaluating a computerized prescriber order entry (CPOE) protocol for managing alcohol withdrawal Implementation of a learning module that educates and credentials medical residents and staff to write PCA orders in the pediatric population Combating drug shortages: comparing the safety and efficacy of oral versus parenteral sodium bicarbonate for urinary alkalinization in pediatric oncology patients receiving high‐dose methotrexate. Treatment of persistent methicillin resistant Staphylococcus aureus bacteremia complicated by antibiotic resistance and source identification Pharmacists impact on clinical outcomes and cost avoidance among patients with uncontrolled diabetes and hypertension Implementation of a pharmacist‐initiated, collaborative, culture follow‐up program in the emergency department 8‐038 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 33 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Efficacy of levetiracetam compared to phenytoin in seizure prophylaxis following traumatic brain injury Evaluation of inpatient chemotherapy patient counseling materials at an academic medical center Intravenous immune globulin challenge in an IgA deficient patient with guillian barre syndrome Implementation of pharmacist‐driven medication reconciliation discharge scripting to reduce readmission rates Identification and education of patients non‐adherent to chronic obstructive pulmonary disease (COPD) medications and evaluation of outcomes Adjunctive ketamine use in managing severe alcohol withdrawal or delirium tremens in the medical intensive cardiac care unit (MICCU) Evaluation of patient safety with extended interval international normalized ratio (INR) monitoring in a pharmacist‐managed anticoagulation clinic Assessment of influenza and pneumococcal vaccination rates after implementation of new processes for vaccination screening, ordering, and documentation. The impact of pharmacy‐led patient counseling on patient satisfaction scores (HCAHPS) 7‐106 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐196 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐071 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐075 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐260 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐139 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐069 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐229 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐123 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318111 Henry Dunnenberger NC 318332 Stephanie J. Dunseith IL 316464 Rachael Durie NJ 318083 Claire Dysart MI 315938 Kelly Earls WV 314624 Reika Ebisu IL 318490 Nicholas E. Eckert IA 317391 Gregory A. Edmiston WA 316750 Nicholas Edmonds OH 34 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Acute opioid overdose: utility of continuous naloxone therapy in an emergency department setting Daptomycin use at Avera Mckennan: an evaluation of indication, cost, and the potential role of alternative novel antibacterial agents for infections caused by gram positive bacteria. Comparison of Post‐
Operative Pain Control in Intra‐Operative Knee Injections for Total Knee Arthroplasty Impact of pharmacist discharge counseling on 30‐
day readmission rates in patients with stroke A comparison of compounded 3‐in‐1 total parenteral nutrition admixture vs. premixed multichamber parenteral solution in a community hospital setting Impact of a pharmacist‐
managed post‐operative pain management protocol in total joint patients in a community hospital Alert fatigue versus overlooked drug‐drug interactions: a study of the impact of clinical decision support software alert trigger sensitivity on an inpatient psychiatric unit. Evaluation of risk factors associated with uncontrolled hypertension 7‐108 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐209 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐040 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐088 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐201 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐090 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐241 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐043 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐137 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318360 Kristin Eginger NC 316964 Nathaniel Ehni SD 316619 Kyle J . Eichelberger MO 316764 Razan El Melik NC 316440 Dillon Elliott TN 318059 Charles Ellis MT 318330 Justin C. Ellison NY 316974 Dina T. Elperin CA 318526 Teresa Mary Elsobky FL 35 | P a g e Implementation of an indigent patient prescription assistance program after discharge at an inpatient behavioral health center Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 315942 Elizabeth Claire Elson MO Methadone Associated QT Prolongation in Pediatric Patients 7‐031 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317852 Kayleigh Emerson TX 8‐291 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318062 Sarah Emrich IN 9‐098 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316059 Bobby I. Endo ID 6‐042 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317374 Chinenye EeJay Enekwa GA 6‐037 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317547 Matthew R. Enell MI 8‐068 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318001 Deborah Kathleen Engelbrecht KY Clinical significance of linezolid minimum inhibitory concentrations (MIC) in patients with methicillin resistant Staphylococcus aureus pneumonia (MRSA) treated with linezolid Standardization of intravenous insulin use to improve patient safety in the critical care unit of an acute care hospital Evaluation of adherence to recommended monitoring guidelines for amiodarone in primary and specialty care clinics Use of intravenous acetaminophen to reduce opioid use in patients undergoing bariatric surgery at a community teaching hospital Evaluation of fidaxomicin use at a large, academic, community‐based medical center Clinical outcomes of alternative meropenem dosing strategies 10‐234 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318604 Katie Erickson ID 6‐047 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317951 Leslie Esparza WA 9‐241 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 36 | P a g e Continuous quality improvement of a pharmacist managed inpatient and long‐term care anticoagulation protocol at the Boise Veterans Affairs Medical Center Revising current pharmacy pain management practice and optimizing the pharmacist role in improving pain management ratings on the HCAHPS survey Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 316139 Monica E. Evans CO 10‐005 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 311482 Sarah E. Fabiano NY 7‐144 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316201 Karyn Ray Fabo NC 7‐073 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315356 Laura Falconieri PA 6‐122 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316354 Amy M. Fanous OH 8‐114 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317259 Diana Farino NY 7‐208 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316154 Noor Fattouh NY 7‐173 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316234 Lindsey Faulks MO 7‐035 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316908 Tamara Fawal‐
Vefali NJ 6‐079 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317170 Ashley Feldman MN Intravenous immunoglobulin and ideal body weight: a medication‐
use evaluation Evaluation of Methods of Education for Emergency Medicine Providers and Utilization in Daily Practice Comparison of risk factors for QTc interval prolongation in hospitalized patients 60 years of age pre‐ and post‐FDA warning for citalopram Incidence and risk factors for infection in patients receiving extracorporeal membrane oxygenation (ECMO) Implementation of a 12‐
week pharmacist lead walking program designed for employees of a private university to increase physical activity and improve overall health of participants Impact of pharmacist involvement on medication reconciliation in the emergency department Evaluation of sliding scale insulin usage in elderly nursing home residents at a VA Medical Center Telephonic pharmacist‐led multidisciplinary management of LDL in patients with uncontrolled diabetes in a family medicine residency clinic Evaluation of vancomycin usage on an inpatient oncology unit in a large academic medical center Evaluation of the utilization of inhaled nitric oxide in hospitalized patients 9‐179 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 37 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day IN Evaluating parenteral nutrition practices before and after pharmacist‐led education Correlation between zolpidem and the incidence of falls in hospitalized patients: a retrospective review Taking a step towards reducing intensive care unit (ICU) delirium and oversedation: decreasing intravenous benzodiazepine infusions while increasing intravenous fentanyl infusions Epidemiological, clinical, diagnostic and pharmacological analysis of adverse reactions to antineoplasic drugs in a tertiary hospital Pharmacy Peer Vaccination 9‐079 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐055 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐244 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐206 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐255 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐230 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐084 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐159 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐006 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316269 Kendra Rose Feltz 317993 Alissa J. Ferrari MO 318189 Nicole A. Ferrigno WA 316943 Monica Ferrit Martin Spain 318647 Joseph Finley WA 317403 James W. Fischer WA 316412 Kristen A. Fischer FL 317149 Lauren Fisher PA 316468 Katy Fisher AL 38 | P a g e Assessment of safety outcomes after a workflow redesign for patients receiving high risk medications. Evaluation of monitoring practices of high dose (off‐
label) citalopram Impact of a clinical‐
pharmacist‐initiated management and azithromycin prophylaxis to prevent chronic obstructive pulmonary disease exacerbations at a family medical clinic Telephonic Interventions in Achievement of Patient Set Health Goals Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Implementation of oral chemotherapy order sets at an outpatient oncology clinic Risk evaluation and mitigation strategies (REMS): ensuring compliance with Medication Guide distribution requirements Implementation of a revised heparin protocol and flow sheet to evaluate patient therapeutic outcomes at a community hospital Performance improvement in the management of thrombotic events with the use of unfractionated heparin Promotion and assessment of expanded vaccination services in a community pharmacy setting Efficacy of an intensive care unit glycemic control protocol in managing the blood glucose of patients undergoing therapeutic hypothermia after cardiac arrest Rate of major bleeding in patients with atrial fibrillation taking dabigatran or rivaroxaban in a real‐
world setting Utilization of dabigatran at a community teaching hospital 10‐150 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐045 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐006 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐237 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐137 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐151 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐234 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐072 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Evaluating the association between proton pump inhibitors and clostridium difficile infection Evaluation of pharmacist interventions and impact in an outpatient pediatric clinic 8‐016 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐183 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315803 Patrick Fleming IL 318305 Megan R Flood ID 316794 Gary Flowers MD 317905 Josh Floyd WA 317177 Sara Flynn MA 318072 Justin M. Fongemie MA 316633 Gabriel Fontaine UT 317938 Michael Forman MI 318494 Jesse Foster DC 317593 Jenna L. Foster SC 39 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Evaluation of use of the hypoglycemia protocol after the addition of apple juice to the medication administration record Statin intolerance due to myopathy in the diabetic population at an outpatient clinic Improving the diagnosis of hepatitis c virus (HCV) in an American Indian/Alaska Native (AI/AN) population by implementing age‐based screening. Do the french prescribers follow exactly the recommendations of just prescription of anti‐
alzheimer medicines in geriatric hospitals Medical management of electrical status epilepticus during slow wave sleep with diazepam in pediatric patients Latent tuberculosis and HIV co‐infection clinic operated by a clinical pharmacist: implications for treatment completion and adherence to follow‐up A Cost‐Benefit Analysis of the Implementation of Alaris Pumps in Preventing Medication Errors in Neonatal and Pediatric Populations Appropriateness of empiric antibiotic therapy for the treatment of urinary tract infection in patients seen in an emergency department: a retrospective analysis Psychoactive medication polypharmacy: an evaluation of prescribing practices on inpatient psychiatric units at TriStar 10‐172 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐251 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐136 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐023 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐207 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐036 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐107 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐213 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐193 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317058 Justin T. Foster IL 318620 LaQuasha P. Foster LA 317653 Dewey Foutz NM 317973 Cecile Francois 317248 Densley E. Francois NY 317348 Tyler Frasch GA 316259 Lauren R. Frasier KS 317716 Christopher M. Frazer SD 315408 Erica Frazier TN 40 | P a g e France Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 6‐160 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐099 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐120 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐304 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐012 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐048 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐081 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐218 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐019 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Centennial Medical Center 317175 Emily R. Frederick PA 315232 Lindsey Nicole Frilling OH 315035 Susan Fry NE 318462 Noriko Fujinami TX 316950 RaeAnne Fuller AZ 316719 Kylee Funk MI 316400 Brooke T. Gabel FL 317907 Wendy M. Gabriel TN 316457 Kara Gadomski DE 41 | P a g e Effect of changing home antihyperglycemic medications upon hospital admission on inpatient glycemic control Augmentation of clozapine with an additional antipsychotic in treatment resistant schizophrenia at the Louis Stokes Cleveland VAMC Pharmacist review of standard pharmaceutical therapies utilized prior to pain clinic referral Implementation of a pharmacist‐managed automatic renal adjustment protocol for select anticoagulation medications Impact of a formulary switch from glargine to detemir insulin Efficacy of dronabinol in combination with ondansetron versus ondansetron alone for postoperative vomiting in neurosurgical patients Analysis of pharmacist‐
provided vancomycin and aminoglycoside pharmacokinetic dosing service Comparison of levetiracetam and phenytoin for seizure prophylaxis after severe traumatic brain injury Successful use of interferon alfa2b in a patient with West Nile virus Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day A systems approach to evaluating a clinical pharmacy service in an academic medical center Establishing a protocol for the inpatient management of pediatric community acquired pneumonia Evaluation of phenobarbital in managing severe alcohol withdrawal in critically ill patients: A follow‐up study Evaluation of effect of pharmacy education on acute myocardial infarction readmission rates Impact of an onsite pharmacist led tuberculin skin testing (TST) service on student compliance Meeting core measures for heart failure: pharmacist medication evaluation and discharge counseling in a community hospital UTILIZATION STUDY OF PEMETREXED IN PATIENTS WITH METASTATIC NON‐
SMALL CELL LUNG CANCER IN A LARGE HOSPITAL IN SPAIN Improving the management of hyperkalemia in a large community hospital 9‐155 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐181 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐177 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐034 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐202 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐105 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐196 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐109 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐075 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐221 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐199 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318239 David J. Gagnon MA 316538 Andrew Brantley Gainey SC 317324 Abu‐Bakr Galaria IL 316230 Kelly Galen MO 315102 Melissa K. Gallian KY 318098 Meghan M. Galloway NC 315171 Mercedes Galvan Banqueri 317288 Dennis Ganyc FL 316133 Nicole B. Ganzer FL 317887 Carmen Garcia 316635 Monique M. Garcia 42 | P a g e Spain Spain NY Prescription drug monitoring program: a new opioid risk mitigation tool at the West Palm Beach Veterans Affairs Medical Center Implementation of a therapeutic equivalence program (TEP) in a tertiary hospital Analysis of adverse drug events associated with inappropriate prescribing utilizing the Screening Tool Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 6‐211 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐051 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐064 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐091 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐151 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐199 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐266 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐025 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐266 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. of Older Persons potentially inappropriate Prescriptions (STOPP) criteria 317005 Sara Garcia Agudo 318575 Davina L. Garls CA 314506 Sara R. Garrett NC 318074 Neil Garver MT 314478 Lauren Z. Gashlin NY 315768 Sarah Lynne Gates TN 317237 Kimberly A. Gathers WV 314052 Andrew Gawlikowski CA 316246 Gerard Gawrys WI 43 | P a g e Spain Detection and analysis of adverse drug reactions through a system coding in a tertiary hospital Use of calcium and magnesium to reduce the incidence and severity of oxaliplatin‐induced neurotoxicity in oncology patients Optimization of clinical decision support in a pharmacy information system Establishing the role of an emergency room pharmacist and justifying their use in a small community hospital setting Adherence to national and institutional guidelines for erythropoietin stimulating agent use at an academic medical center Evaluation of medication events during surgical procedures in a multi‐center healthcare system Evaluation of the use of rifaximin and identification of therapies for hepatic encephalopathy at a large teaching institution The outcomes of a decentralized pharmacist in the intensive care unit in a military treatment facility Evaluating clinical outcomes for MRSA coverage in MRSA nasally colonized and non‐
colonized veterans: potential considerations for antimicrobial stewardship decision making. Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Development and implementation of antimicrobial order set for febrile neutropenia at a community‐based teaching institution Incidence and risk factors for the development of acute renal insufficiency among high‐risk pediatric neuroblastoma patients following myeloablative consolidation therapy with autologous stem cell rescue Evaluation of dexmedetomidine use in a pediatric population 9‐035 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐132 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐157 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Impact of concurrent antiretroviral therapy on the safety and efficacy of clopidogrel Evaluating the efficacy of aminoglycosides or quinolones for the treatment of nosocomial pneumonia or sepsis with piperacillin with tazobactam in an inner‐city hospital Role of gabapentin in postoperative pain after total knee arthroplasty (TKA) Pharmacists attitude towards non‐traditional pharmacy practice residency programs in Veterans Affairs Medical Centers Comparison of side effects between L‐asparaginase and PEG‐L‐aspargase in severance hospital pediatric acute lymphoblastic leukemia patients Pharmacoeconomic impact of pharmacy interventions in a tertiary care teaching institution 6‐034 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐190 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐117 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐276 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐049 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐009 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316579 Xuan Ge CA 316729 Julie Gegg MA 317098 Jody L. Gembarski PA 317008 Allison M. George GA 316499 Jasmine George NY 317920 Megan P. Germer KS 317257 Mallory Elaine Gessner‐
Wharton TX 316758 Min‐jung Geum Korea 317378 Jinwi T. Ghogomu 44 | P a g e DC Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 317161 Amanda Giancarelli NY Pharmacist assessment of micronutrient deficiencies in adults on nutrition support 7‐206 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318454 Caitlin Gibson TX 8‐303 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316994 James N. Gibson WA 9‐227 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318403 William Gibson WA 9‐247 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 315587 Shawn Gibson CT 10‐020 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318367 Rebecca Gieser MT Oral Naloxone for the Treatment of Opioid‐
Induced Constipation in the Medical ICU Assessment of preemptive urine toxicology screening practices for patients treated in a comprehensive cancer center pain clinic Effect of a pharmacist‐based targeted discharge teaching and post discharge telephone follow‐up on 30 day readmission rates Alcohol use disorder screening upon admission: a prospective assessment of the AUDIT tool Medication reconciliation: establishing a baseline error rate 8‐093 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318096 Elise Gilbert IL 10‐187 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 314207 Danielle M. Gingras FL 10‐056 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317698 Danielle Gionet NY 7‐221 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316029 Daryl Glick NY 7‐171 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315519 Brianna L. Gohdes ND 7‐114 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 45 | P a g e Benefits of electronic versus manual billing of anesthesia gases at an academic medical center Percentage of patients within Bay Pines VA on opioids with opioid agreements Evaluation of efficacy of atypical antipsychotic metabolic monitoring at the Stratton Veterans Affairs Medical Center Safety and effectiveness of enoxaparin dosing weights for the treatment of venous thromboembolic disease Utilization of a pharmacist in the medical home model and its impact on quality scores in disease management of diabetic patients in the ambulatory Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Assessing diabetes knowledge and impact on achieving hemoglobin A1c goals in a veterans affairs population Effects of topical tranexamic acid on bleeding post‐total knee arthroplasty 7‐086 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐014 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. Evaluation of Micafungin Usage 10‐108 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. Relationship between adherence to antiretroviral therapy and the use of recombinant human erythropoietin in patients with HIV‐HCV coinfection Implementation of a protocol for the management of agitated delirium in the emergency department: a novel approach utilizing low‐dose ketamine Assessing patients with chronic non‐malignant pain who are receiving daily doses of 200 mg or greater of morphine equivalent opiate treatment for safety and efficacy. Stress ulcer prophylaxis medication use evaluation 6‐203 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐107 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐195 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐173 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐148 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐069 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. care setting 316639 Svetlana Goldman NC 317573 Jamie M. Gomes MD 317262 Rebecca Gonzalez 316749 Javier Gonzalez Bueno Spain 318124 Megan Goodale NC 316247 Sanaz Goodarzi NV 317916 Amy Goodpaster PA 315706 Elizabeth K. Gorski IL 315778 Sharita Gause Gosa FL 46 | P a g e FL Evaluation of antibiotic dosing in pediatric patients discharged from the emergency department Metabolic support team (MST) service quality assurance Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Vancomycin‐induced and piperacillin/tazobactam‐
induced acute nephrotoxicity: a retrospective review Assessment of outcomes in veterans with poorly controlled diabetes mellitus: a retrospective study of the impact of a pharmacist‐run chronic disease management clinic Evaluation of pneumonia treatment practices in a community medical center 10‐213 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐104 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐285 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Evaluation of anticoagulation with intravenous heparin in post‐
operative left ventricular assist device (LVAD) patients A retrospective analysis of the efficacy and safety of bloodless medicine protocols Evaluation of indications and length of treatment for vancomycin and piperacillin/tazobactam combination therapy Evaluating the effect of U‐
500 insulin therapy on glycemic control in type 2 diabetic veterans Oral antipsychotics versus long‐acting injectable antipsychotics: efficacy in preventing recidivism Comparison of continuation electroconvulsive therapy, antidepressant alone, and combination therapy for treatment of depression in the veteran population Impact of lansoprazole co‐
administration on the elimination of high dose methotrexate in the pediatric oncology 8‐065 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐015 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐058 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐133 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐204 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐140 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐008 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315810 Jessica L. Gottmann KY 314623 Kyleigh Gould KS 317450 Jared Gower TX 317427 Aimee Gowler MI 318458 Arthur Graber DC 318152 Brian Grace MO 317217 Joseph A. Granata NM 315307 Lauren Grant KY 314636 Emily N. Gray IL 316630 Ashley L. Greene CO 47 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Evaluating the impact of rapid gram‐positive blood culture identification and antimicrobial stewardship program (ASP) intervention on the management of bloodstream infections A Procalcitonin Guided Algorithm as a Tool for Pharmacy Implemented Antibiotic Stewardship in Lower Respiratory Tract Infections Guideline compliance for treatment of Clostridium difficile infections 9‐029 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐100 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐147 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. population 316012 Sharan Grewal CA 316971 Jonathan Grey FL 317967 Karen T. Grice OH 318109 Chelsea L. Grombir MI Characterization of tigecycline use at a large academic medical center 8‐077 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317603 Craig R. Grzendzielewski IL 10‐180 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316920 Laura Guido PA 6‐153 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317163 Gina M. Guinta MA 9‐136 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318089 Kathryn M. Guinto TN Treatment response predictors in Clostridium difficile infections and the effects of protocol regulated treatment on patient outcomes Evaluation of bleeding risk factors and the management of acute hemorrhage in patients taking dabigatran therapy Evaluation of adverse effects in returning veterans taking once versus twice daily sustained release lithium: a pilot study Cyclosporine versus tacrolimus: a comparison of patient outcomes and adverse effects in heart transplant patients before and after a hospital protocol change 8‐222 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 48 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Effectiveness of a patient‐
centered model in the academic pharmaceutical skills laboratory Appropriate use of piperacillin/tazobactam: an evaluation of dosing and indication Identification of positive hepatitis C screening results in a primary care clinic and implementation of a referral for treatment algorithm Multiple parity and incidence of anemia in women: pharmacy implications Alert fatigue experienced by pharmacists during order verification 9‐018 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐081 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐111 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐250 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐017 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐150 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐166 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐125 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐110 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐184 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐197 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318511 Tyler H. Gums AL 318261 Matthew Gurka MI 318618 Justinne Guyton NC 318614 Valentina M. Guzman LA 318456 Julie Haase AL 318046 Katie Hackenson MA 315665 Kyle Hacker NY 315625 Alyssa Halczli MA 311909 Sarah E. Hallinan PA 318131 Jessica Hammes MN 318333 Zhe Han 49 | P a g e IL Evaluating the impact of a telephone‐based, pharmacist‐run insulin management program Use of granulocyte colony stimulating factors according to evidence based guidelines in the veteran population The Effect of Selective Serotonin Reuptake Inhibitors on Thiazide‐
Induced Hyponatremia in a Male Veteran Population: A Pilot Study Creation and implementation of antimicrobial guidelines at a Veterans Affairs medical center Quantifying hepatitis B vaccination rates in patients with diabetes mellitus in an ambulatory care setting Comparison of Two Pharmacy Practice Models for Inpatient Pharmacokinetic Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 10‐036 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐035 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐003 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐183 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐120 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐102 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐142 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐143 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. Management of Vancomycin in Special Patient Populations 316671 Mariam Hanna CT 315769 Monica M. Hannawa MI 316188 Seema Harikumar DC 318094 Jennifer Harmon PA 318285 Christopher M. Harms KS 318006 Courtney L. Harper NC 316240 Justin Harris PA 318649 Jason D. Harris NM 50 | P a g e Increasing efficiency and consistency of documentation of pharmacist interventions Interprofessional education and practice: outcomes of physician and pharmacist lead rounds for general medicine patients Evaluating medication adherence in human immunodeficiency virus (HIV) patients utilizing prepared pillboxes A comparison of medical and pharmacy utilization for members on buprenorphine/naloxone in a restricted Medicaid population versus a non‐
restricted Medicaid population Evaluation and implementation of a multi disciplinary approach to the reduction of hospital acquired Clostridium difficile infections in a large suburban community hospital Fact or fiction: nephrotoxicity in the modern era of parenteral vancomycin therapy Long‐term blood pressure goal achievement in kidney and liver transplant patients within an underserved community Implementation and impact of a pharmacist managed diabetes clinic in the care of Native Americans patients with diabetes Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Development and implementation of a competency framework for pharmacists utilizing a new computerized physician order entry (CPOE) system within a large tertiary medical center CYP1A2 genotype and phenotype analysis in a cohort of pharmacy students as a model for teaching pharmacogenomics Novel program using pharmacy technicians to collect medication histories in the emergency department Pharmacy implemented protocol for analgesia, sedation, and delirium in a surgical intensive care unit Evaluation of Bivalirudin for Non ACS Indications 8‐299 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐054 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐055 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐200 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐057 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐084 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐203 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐233 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐145 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318410 Byron R. Harris TX 312706 Shanna Harris FL 312932 Coleen Hart FL 318425 Jennifer Hartman NV 318029 Aaron Hartmann MO 318338 Megan Hartranft MI 318512 Michael Harvey NV 316518 Madison Hatch UT 315595 Ron Hausner IL 51 | P a g e Application of a clinical trials effort tracking tool to workload management in an academic investigational drug service Evaluation of a dashboard tool to standardize the monitoring and comparison of psychotropic prescribing in Veterans Affairs (VA) community living centers (CLCs) Oral beta‐lactams versus oral fluoroquinolones for urinary tract infections Evaluation of perioperative antimicrobial prophylaxis with nafcillin for craniotomy procedures Time Submissi
on ID Primary Author Full Name State/ Country 314096 Emily Hays UT 318586 Yijing He WA 317272 Danielle C. Hebel MO 316155 Rivka Hecht NY 316197 Cassie R. Heffern MO 317216 Kalie Heideman KS 316205 Alexander Heine OH 317909 Jenna Hendershot NY 315370 Whitney L. Henderson KY 317322 Rosa L. Hernandez TX 52 | P a g e Title Pharmacist intervention to decrease risk of hypoglycemia in older patients with diabetes mellitus Implementation and Assessment of Pharmacist Consultation for Discharge Medication Reconciliation Evaluation of depression and measurement of testosterone levels Alcohol withdrawal management practices in hospitalized patients at a teaching institution Evaluation of clinical pharmacist recommendations in a family medicine ambulatory care setting Implementation of medication education groups in an inpatient behavioral health unit Evaluation of the use of prothrombin complex concentrate for hemostasis in emergent situations outside of intracranial hemorrhage Adjustments in vancomycin requirements in the obese population: A retrospective review Evaluation of a dofetilide initiation protocol at a community hospital Impact of targeting and achieving higher vancomycin trough concentrations on acute kidney injury in a neonatal intensive care unit Session/ Board Number Day Time 6‐227 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐252 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐046 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐174 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐033 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐112 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐110 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐228 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐206 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐278 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 315326 Brittany O. Herring FL Impact of acetaminophen in reducing opioid use postoperatively 10‐062 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315347 Mohamed A. Hersi TX 8‐238 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317580 Emily E. Herstine MN 9‐182 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 315303 Joe Hessell NJ 6‐063 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316401 Megan Hewitt AL 9‐005 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 315537 Maho Hibino WA Evaluation of osteoporosis prevention in patients receiving chronic corticosteroids at an academic veterans affairs medical center Retrospective review of antibiotic selection and duration of therapy for community acquired pneumonia at a large quaternary care community hospital Thalidomide‐associated transient peripheral neuropathy in a patient with erythema nodosum leprosum Intramuscular ziprasidone utilization in a community pediatric emergency department Comparison of shortened versus extended carboplatin desensitization protocols 9‐218 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317934 Tiera L Hickman PA 6‐174 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316163 Laurel Anne Highberger CT 10‐025 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316842 Kristen M. Hillebrand FL 10‐098 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318055 Maeghan Elizabeth Hilliard WI Appropriateness of intravenous proton pump inhibitors in a large, community teaching hospital Impact of pharmacist intervention on optimizing pain management in high‐
dose opioid users Implementation of a sepsis management protocol and education program in a community hospital Medication usage evaluation of gastrointestinal (GI) prophylaxis in a community hospital setting and the impact of pharmacists on 6‐282 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 53 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 9‐235 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐220 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐040 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐122 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐226 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐157 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐086 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐001 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. reducing inappropriate use 317663 Tiffany Himes WA 317971 Melisande D. Hinds TN 317853 Risa Hiroshima GA 316740 Tasha Hissett OH 312074 Chin Chin Ho Taiwan 315345 Timothy Ho NY 316490 Jasmine J. Ho IN 315267 Kang Chi Ho CO 54 | P a g e Improving patient satisfaction and Hospital Consumer Assessment of Healthcare Providers & Systems (HCAHPS) scores through medication education during hospital admission Comparison of high‐dose versus standard‐dose dexmedetomidine in critically‐ill patients Bolus dosing hyperosmolar therapy versus continuous infusion of hypertonic saline in patients with traumatic brain injury: a retrospective analysis Accuracy of admission medication history following implementation of a standardized nursing process in the emergency department Effects of A Policy Lifting Reimbursement Restrictions with Endoscopy for Anti‐
ulcer Drugs Impact of inpatient warfarin counseling by pharmacists on patient knowledge, post‐
discharge follow‐up and clinical outcomes Evaluation of medication orders in the emergency department Evaluation of clopidogrel versus prasugrel prescribing habits in re‐thrombosis and bleeding event rates in post myocardial infarction with percutaneous coronary intervention patients Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Stress ulcer prophylaxis for intensive care unit patients with low Glasgow Coma Scale scores Assessing medication and allergy discrepancies discovered by medication reconciliation technicians in the emergency department Evaluation of adherence to an intravenous acetaminophen guideline at a community health system Use evaluation of ceftaroline fosamil 6‐240 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐227 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐176 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐219 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐246 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐013 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐139 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐201 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐101 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐165 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317407 Quang Phung Hoang UT 318361 Susan A. Hobson TN 317284 Matthew Hoch IL 317649 Amanda L. Hodges NY 318337 Laura Hoekstra WA 317209 Amanda L. Hoffbeck CO 317665 Chas Hoffmann OH 318610 Jennifer M. Hogg IL 315321 Ashleigh Hogue OH 314218 Kenzie G. Hohman MN 55 | P a g e Implementation of pharmacist led heart failure discharge counseling and medication therapy management services A correlation in antimicrobial use and an increased incidence of Clostridium difficile infection in a pediatric oncology unit. Evaluating the impact of a budget neutral pharmacist‐
led intervention program for high‐risk patients in a community hospital emergency department Impact of pharmacist‐led post‐discharge telephone intervention on heart failure readmissions Evaluation of dabigatran usage in a 500‐bed tertiary care medical facility Cross‐sectional population‐
based study examining differences between US rural and non‐rural adults with congestive heart failure (CHF) in the prevalence of the use of American College of Cardiology Time Submissi
on ID Primary Author Full Name State/ Country Title Foundation/American Heart Association (ACCF/AHA) recommended beta‐
blockers Implementation of a pharmacist‐driven pertussis vaccination clinic at a community hospital Compliance with metabolic monitoring treatment guidelines for patients taking second‐generation antipsychotic agents and hospitalized on an acute inpatient psychiatric unit Characterization of adverse events associated with stress ulcer prophylaxis in the critically ill The Use of Zoledronic Acid and Pamidronate in the Inpatient Setting Session/ Board Number Day Time 6‐237 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐227 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐106 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐085 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316969 Kelly Ann Holcomb UT 317893 Erica Hoot NY 315800 Matthew J. Hoover OH 316546 Gena Hope NC 315932 Michelle Horng MI Evaluation of albumin use in intensive care units 8‐037 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316224 Zachary M. Horning NC 7‐077 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317814 Diana K. Houng MA 9‐144 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318270 Michelle House TX 8‐297 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316210 Debbie Hsu NY Evaluation of removal of nicotine inhalers on aggression and agitation in an adult inpatient psychiatry unit Evaluation of peri‐ablation anticoagulation with dabigatran at a large academic medical center Routine medication counseling by pharmacists within the hospital and its effect on hospital consumer assessment of healthcare providers and systems (HCAHPS) scores Financial impact of potential conversion from insulin vials to insulin pens in Veteran inpatients at VA Hudson Valley Healthcare System (VA HVHCS) 7‐176 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 56 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Impact of Matrix‐Assisted Laser Desorption/Ionization‐
Time of Flight (MALDI‐TOF) with Antimicrobial Stewardship Team Intervention on Antibiotic Therapy and Outcomes in Adult Patients with Bacteremia and Candidemia Retrospective review of vancomycin versus metronidazole as first‐line treatment for Clostridium difficile infection in cancer Evaluation of daptomycin use in a community teaching hospital. 8‐027 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐041 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐119 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Implementation of an emergency department chronic pain management directive in a community hospital A Protocol for administration of partial doses of solid medications in a pediatric institution Evaluating patient outcomes associated with a heparin induced thrombocytopenia protocol Evaluation of a hyperglycemia management protocol at a community health system Standardizing the necessity for off‐label informed consent: a pediatric undertaking. Sterility Analysis of Cystic Fibrosis Liquid Multivitamins 10‐160 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐179 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐008 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐154 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐170 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐230 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐210 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315416 Angela Huang MI 316250 Esther Huang MI 316557 Megan Huebner OH 316237 Anna Hufendick IL 318013 Rachel L. Hughes PA 316921 Adrian C. Hui MD 316147 Ashton Marie Hullett IL 317800 Kelly L. Hummel PA 315668 Travis James Hunt UT 315666 Amanda Mahala Huskey KY 57 | P a g e Overuse of proton pump inhibitors: an opportunity for pharmacist intervention Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Evaluation of prothrombin complex concentrate (PCC) dosing of 25 IU/kg vs 35 IU/kg for rapid anticoagulant reversal in head trauma patients Intravenous N‐
acetylcysteine administration in acute liver injury Evaluation of nursing compliance with a critical care insulin correction table 6‐136 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐179 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐173 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐260 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐083 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐153 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐169 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐231 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316143 Thao Huynh PA 316281 Quy Huynh NY 317065 Alifiya F. Hyderi IL 316789 Bethany W. Ibach OK 316341 William Ifeachor IN 316080 Alina Ilkevitch IL 315806 Tayla K. Inderlin NY 315959 Shannon Inglet UT 316380 Emily N. Israel MI Urinary tract infections in kidney transplant recipients with ureteral stents 8‐045 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317995 Nadine Jaber CT 10‐046 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316377 May Jabra NY Increasing compliance with 23‐valent pneumococcal vaccination (PPV23) in high risk pediatric patients Evaluation of medication administration times before and after implementation of an automated dispensing 7‐183 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 58 | P a g e Duration of intrathecal morphine effect in children with idiopathic scoliosis undergoing posterior spinal fusion Utilization of objectives from the ASHP 2015 and PPMI initiatives to inspire pharmacy practice change in a VA medical center Chronic Methotrexate Use in Rheumatoid Arthritis and Psoriatic Arthritis and Compliance with Liver Biopsies Evaluation of a pharmacy‐
led intravenous‐to‐oral antibiotic conversion protocol Seizure prophylaxis in traumatic brain injury patients Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Retrospective chart review of dabigatran prescribing at the West Palm Beach Veterans Affairs Medical Center Adherence to the Clostridium difficile infection (CDI) clinical practice guidelines and outcomes in a community hospital setting Validation of heparin protocols in patients with venous thromboembolism and acute coronary syndromes Evaluation of Clostridium difficile pcr utilization and subsequent treatment based upon the published guidelines Impact of a pharmacist run medication management clinic on hypertensive diabetic patients at a rural veterans outpatient clinic Impact of the implementation of procalcitonin assay on antibiotic usage and length of stay in hospitalized adult patients at a community acute care hospital Evaluation of a faculty‐
directed doctor of pharmacy student medication reconciliation service in a hospice setting. Assessment of empiric linezolid utilization in medical intensive care unit patients 10‐074 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐245 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐099 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐149 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐215 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐190 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐203 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐225 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. system 316132 Jonathan L. Jackson FL 315008 Golby Jalali VA 317686 Ashley James NC 315785 Monica Jandura IL 318169 Carrie A. Jansen SD 314620 John M. Jantz TN 316977 Rachel Jarbe NY 317857 Deena Jecen NY 59 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 316503 Jaclyn A. Jeffries IN 9‐087 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316514 Franklin H. Jeng NY 7‐191 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317611 Megan Jensen NY 7‐216 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315781 Ashley Jensen MN What is the impact of consumer health literacy on the potential for unintentional overdose with acetaminophen?: patient's perspectives. Evaluation of the impact of reduced heparin potency and protocol compliance on clinical practices. Evaluation of the use of sliding‐scale insulin in hospitalized medicine patients with type 2 diabetes Chronic Pain Management Policy Compliance in the Emergency Department 9‐174 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 312967 Grace E. Jiang NY 7‐147 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318012 Alberto Jimenez‐
Morales Spain 6‐224 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318436 Elizabeth A. John TX 8‐301 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316648 Jessica Johnson OR 6‐102 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317540 Amanda S. Johnson PA 6‐166 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 60 | P a g e Assessment of high alert medication related adverse drug events (ADE) before and after implementation of a pharmacy‐driven medication reconciliation program Prediction of renal toxicity of tenofovir and follow‐up in liver transplant patient with de novo hepatitis B previously treated with adefovir Furosemide resistance in the setting of hypoalbuminemia: a retrospective review of albumin and furosemide coadministration Pharmacy resident dual‐
appointment and a decrease of salary costs in the pharmacy Acute esophageal bleeding: the manifestation of chronic schistosomiasis in a recently relocated Ethiopian male Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 315947 Yun Teng Johnson WI Medication use evaluation of heparin infusions in pediatric patients 6‐265 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 314634 Jimmy Johnson NY 7‐155 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317093 Sharika Johnson DC 8‐006 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317189 Doneshia S. Johnson TX 8‐273 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315744 Amanda K. Johnson MN 9‐173 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317635 Ashley D. Johnson KY 10‐231 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315568 Abby Johnstone WI 6‐263 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317253 Brittany Jonap TN 8‐213 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 314151 Laura T. Jones NY Retrospective analysis of dabigatran 75 milligrams twice daily in the renally impaired Recognizing the association between health literacy and medication adherence in minorities Clinical outcomes evaluation in patients with skin and soft tissue infections treated based on guidelines recommendations Development of a scorecard to track pharmacy metrics that align with the organizational goals of profitable growth and clinical, operational and service excellence Improving status epilepticus treatment and management of critical care patients using a guideline directed protocol and order set in a rural community hospital Evaluation of pediatric equations for calculating estimated glomerular filtration rate and the effect on drug dosing: are we doing our best? Evaluation of a pharmacist‐
driven automatic IV to oral program in a critical care population Efficacy of a 1mg alteplase dose for treatment of catheter occlusion 7‐150 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315764 Mathew Jones MI 8‐034 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 61 | P a g e Evaluation of tobramycin use in medical critical care patients at a tertiary care hospital Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 318578 Charles W. Jones CT 10‐053 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317640 Jennifer A Jones LA 10‐246 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 311522 Jennifer Joo CA 9‐021 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317902 Tiby B. Joseph TX 8‐293 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316206 Danielle Joset NY 7‐175 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318570 Kim T. Julien FL Determining the efficacy of weight‐based prophylactic antibiotics in total hip and knee replacement surgeries Evaluating time to therapeutic trough with pharmacist‐managed vs physician‐managed vancomycin dosing in adult medical/surgical patients with normal renal function The Effect of Palifermin on Hand‐Foot Syndrome in Hematopoietic Stem Cell Transplant Patients Clinical outcomes differences associated with strain variants of C. difficile compared to wild‐type strains Evaluating the use of dexmedetomidine in the medical and surgical intensive care units at a large academic medical center Statin‐fibrate safety and efficacy initiative 10‐138 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317683 Michael Justice VA 6‐252 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318342 Katie Kahle OH Assessing the effect of pharmacist intervention on the management of chronic hypertension in central appalachian patients. Impact of a pharmacist‐led task force on safe opioid use in a community hospital 8‐170 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318254 Amanda R. Kahn IL 10‐193 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316638 Joseph A. Kalis CO Evaluation of gender differences on medication non‐adherence in heart failure patients Sustainable growth: implementation and evaluation of a protocol for colony‐stimulating factor use at a community hospital 10‐009 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 62 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Development and implementation of a pharmacist service to reduce readmissions for hyperglycemic crisis Evaluation of pharmacist‐
directed medication counseling to enhance antidepressant adherence and PHQ‐9 scores in patients with depression. Analysis of outcomes after implementation of diabetes focused comprehensive drug therapy management services for Medicare beneficiaries in a primary care clinic. Evaluation of electrolyte replacement in a critical care setting at an academic Veterans Affairs Medical Center Intravenous immunoglobulin (IVIG) use in patients at an academic medical center: does practice reflect guidelines? Development of a colistin‐
dosing protocol in an academic medical center 9‐226 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐058 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐243 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐253 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐148 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐022 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐008 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐058 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐193 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316830 Lisa Kallas WA 315972 Marisa Joy K Kaluhiokalani HI 318166 Tara W. Kamprath WA 316297 Reagan Kanne TX 312973 Eric Kanouse NY 318524 Mamta V. Karani MD 317364 Cassandra Ann Karish DC 317195 Mae Kasha MI 315104 Chad Kay NV 63 | P a g e The use of methadone alone and in combination with other QT prolonging medications in the pediatric cardiac intensive care unit Assessment of a revised heparin dosing protocol for patients undergoing therapeutic hypothermia Implementation and impact of an atrial fibrillation anticoagulation clinical reminder on guideline compliance to oral anticoagulation in multiple Veterans Integrated Service Networks Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Inducibility and characterization of oxacillin susceptible mecA gene positive Staphylococcus aureus obtained from outpatient wounds Prescribing practices and appropriate use of piperacillin‐tazobactam 9‐116 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐082 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐118 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐128 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐059 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐094 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐167 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐033 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐224 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317839 Megan K. Kehrli KS 316403 Ashley M. Kelleher FL 318110 Patrick M. Kelley KS 316935 Sarah E. Kelling OH 317200 Corie Kellogg MI 318316 Jennifer S. Kelly NJ 317620 Kathleen Kelly PA 315730 Elizabeth M. Kelly MI 316367 Logan Kelly WA 64 | P a g e Impact of procalcitonin‐
guided antibiotic therapy in lower respiratory tract infections and COPD exacerbations in an academic and community hospital setting Community pharmacy transitions of care program for patients with managed Medicaid Sedation monitoring by Richmond Agitation‐
Sedation Scale (RASS) in critically ill patients on propofol at Mercy Health Partners (MHP) Evaluation of intravenous (IV) acetaminophen use Impact of pharmacist counseling on reduction of 30 day readmission rate following hospital admission for heart failure exacerbation Development of predictive risk model to identify patients for care management interventions related to potential adverse medication events Development of a postgraduate year two (PGY2) health‐system administration residency Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 317027 Audrey Michelle Kendra OH 8‐129 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317720 Jennifer Kerns NC 7‐100 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317137 Michael W. Kesti MN 9‐178 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318317 Ayesha M. Khan OH Comparison of clinical outcomes in sepsis patients following treatment with ketamine or etomidate use in rapid sequence intubation Evaluation of prescribing patterns for Clostridium difficile infection in a community hospital Evaluation of bivalirudin use in patients presenting with a low bleed risk prior to percutaneous coronary intervention (PCI) Predictors of resistance to erythropoietin therapy in chronic kidney disease 8‐168 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317011 Kristin M. Kielar NY 7‐204 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317626 Minhye K. Kim OK 7‐263 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318435 Jeannie Kim CA 9‐047 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318601 Min Jeung Kim CA 9‐053 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 315772 Mi Hye Kim CT 10‐022 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315357 Lauren King PA 6‐123 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 65 | P a g e Impact of clinical pharmacy interventions in an outpatient renal transplant clinic: a pilot study Concordance with the infectious disease society of America (IDSA) guidelines for uncomplicated urinary tract infections at an academic medical clinic Evaluation of glycemic control outcomes and performance improvement in non‐critically ill patients initiated on a basal‐bolus insulin regimen. Impact of pharmacist driven interventions on adverse events related to opioid analgesic use Evaluation of the prescribing pattern and safety of antipsychotics in patients with dementia in a community teaching hospital Atrial fibrillation prophylaxis in cardiothoracic surgery patients Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Comparison of fosphenytoin and levetiracetam for seizure prophylaxis following pediatric traumatic brain injury Evaluating the benefits of a multimodal approach for post‐operative pain control with intravenous acetaminophen and ketorolac status‐post colon resection surgery Assessment of antibiotic use in response to urinalysis results: an observational, prospective study Evaluation of patient understanding of medication instructions after hospital discharge Establishing timely medication reconciliation as a standard of care for veterans living in nursing homes Use of antipsychotics for acute ICU delirium at discharge 6‐239 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐215 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐019 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐018 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐171 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐121 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐267 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐012 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐015 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐206 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317295 Monica King UT 317709 P. Brittany King TN 315513 Matthew King CT 315166 Jennifer L. Kinney CT 317819 Jamie N. Kinscherff PA 315343 Andrew Kirk PA 317452 Holly Kirk WV 317263 Omayma Ahmed Kishk MD 318507 Anna U. Kit AZ 315653 Caitlyn D. Klein SD 66 | P a g e Retrospective evaluation of phenytoin level monitoring in adult patients at a large academic medical center Antibiotic prophylaxis in adult patients on extracorporeal membrane oxygenation Initiation of a pharmacist run diabetes and cardiovascular prevention program at a rural Indian health service hospital Implementing an outpatient antimicrobial stewardship program in a rural veterans healthcare setting Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Use of clonidine to assist with morphine weaning in neonatal abstinence syndrome Standardization of allergy profile documentation and referral for penicillin skin testing Impact of a pharmacist‐
driven antimicrobial stewardship program for patients in the intensive care unit admitted with sepsis Evaluating selective serotonin reuptake inhibitor (SSRI)/serotonin‐
norepinephrine reuptake inhibitor (SNRI) use in post‐
traumatic stress disorder (PTSD) patients prescribed a second‐generation antipsychotic (SGA) Pharmacist risk assessment and the effect of growth factor given as primary prophylaxis on the incidence of febrile neutropenia Use of bethanechol or tamsulosin following urethral urinary catheter removal to prevent reinsertion of indwelling urinary catheter in neurosurgery patients Impacting the length of stay and CMS core measures in patients with community acquired pneumonia through antimicrobial stewardship and patient counseling. Identifying patients at high risk for hospital use and drug‐related problems 10‐235 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐272 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐104 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐192 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐269 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐230 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐138 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐052 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318010 Jordan M. Klein KY 316889 Karen Klosinski WI 317118 Martha Susanne Knoblich FL 314498 Tracie M. Kobayashi NV 316520 Sara Koberstein WI 317447 Philip W. Kociemba KY 316187 Yevgeniya Kogan PA 316924 Lianne Kokoska MI 67 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Interdisciplinary Team Approach to Improve Compliance of Pneumonia Core Measures Impact of pharmacy‐driven education for the medical staff on the prescribing of acid suppression therapy at Exempla Lutheran Medical Center Impact on the INR of adding either trimethoprim or moxifloxacin to warfarin therapy Controlled trial comparing dyslipidemia outcomes between clinical video telehealth to conventional care Extended‐Infusion Zosyn: An Investigation into a Novel Clinical Outcome 8‐165 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐004 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐147 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐112 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐096 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐026 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐204 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐162 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐060 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐092 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318292 Natalie J. Kolehmainen OH 315970 Aleksandra Kolodziej CO 316592 Harold R. Kolonich PA 316261 Courtney Kominek OH 315358 Ben L. Kong OR 315366 Elizabeth A. Koselke MI 318562 Alexander P. Koudelka NV 315644 Michelle A. Krawczynski NY 318217 Kathryn L. Krei MO 318008 Ronny Krejci NJ 68 | P a g e Evaluation of patient and provider satisfaction with a pharmacist‐managed outpatient oral anticancer therapy program Impact of intravenous fat emulsion shortage on adult parenteral nutrition patients Pharmacist‐managed urinary culture call‐back program in an urban academic emergency department Evaluation of the impact of a pharmacy‐driven protocol on argatroban use Implementation of a pharmacist counseling service to reduce the rate of congestive heart failure (CHF) readmissions and improve patient satisfaction. Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Implementation of an intravenous (IV) workflow management system and the effect on patient safety and pharmacy efficiency in a community hospital Comparing Acceptance Rates of Clinical Pharmacist Interventions in the Emergency Department in a Small, Community Hospital vs. a Large, Academic Medical Center Bubble, bubble, toil and trouble: Assessment of total parenteral nutrition (TPN) compounder alerts Utilizing electronic medication requests to identify missing medications within a pediatric hospital Evaluation of a glycemic control protocol in cardiothoracic surgical patients Implementation of a discharge medication reconciliation pharmacist position to decrease medication errors and improve hospital readmission rates Withheld insulin detemir and the incidence of hyperglycemia among inpatients at Mercy Health Partners Effect of medication changes during hospitalization on post discharge medication discrepancies Weight‐based dosing of heparin in morbidly obese patients for the treatment of venous thromboembolism 7‐067 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐116 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐098 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐030 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐261 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐239 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐042 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐225 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐133 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 315432 Andrew Krupp NC 316470 Jaclyn Kruse OH 315034 Kara D. Krzan OH 315570 Jennifer Kuhns MI 316141 Lisa Kurczewski WV 317939 Carla M. Kwon WA 316267 Elizabeth Kyle MI 318296 Juliana Kyle TN 315804 Sandra La PA 69 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Effect of pharmacist implemented patient education in general medicine units Assessment of HIV genotypes of newly enrolled patients in a Ryan White HIV clinic from 2010 through 2012 Analysis and implementation of point of care International Normalized Ratio testing in home care patients treated with warfarin. Effectiveness of the current weight based heparin protocol in obese patients 7‐068 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐254 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐264 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐066 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐261 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐062 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐044 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐149 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐076 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐223 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315528 Neil Labak NC 315318 Kelsey Lackey OK 315593 Lindsey M. Ladell WI 315684 Marie A. Lafosse FL 316640 Daniel P. Laine TX 318034 Kelsey Laks NH 316337 Thanh Phuoc Lam MI 317986 Shirley M. Lam MA 318091 Eric Lambart MI 317837 Drew Lambert NY 70 | P a g e Evaluating potential for minimizing use of proton pump inhibitors at a community‐owned health system Evaluation of heparin for the treatment of venous thromboembolism (VTE) before and after the implementation of a weight‐
based dosing adjustment protocol Determining which measure of renal function best predicts the development of myalgia in patients on statins Implementation of a pharmacist‐driven education‐based program to standardize medication counseling Appropriate use of stress ulcer prophylaxis: an evaluation of indications and stop criteria Preceptor and student perceptions of drug information assignments during introductory and Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Evaluation of the pharmacokinetics and pharmacodynamics of vancomycin in morbidly obese patients compared to non‐obese patients Fresh frozen plasma (FFP) usage review 10‐017 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐130 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. Outcomes and monitoring of patients treated with dabigatran or rivaroxaban for atrial fibrillation Evaluation of medication error reduction with pharmacist‐conducted admission medication reconciliation in an emergency department Impact of patient medication education by a pharmacist on patient satisfaction through hospital consumer assessment of healthcare providers and systems (HCAHPS) scores Implementation of clinical pharmacy services in a community tertiary‐care emergency department (ED): a one‐month pilot program. Assessment of anti‐Xa levels with prophylactic enoxaparin dosing in obese patients Evaluation of a daily interruption of sedation protocol pre and post implementation Evaluation of factors affecting early therapeutic vancomycin troughs 10‐170 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐234 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐198 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐005 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐184 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐145 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐141 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. advanced pharmacy practice experiences 318319 Kristin Lambert CO 316526 Carolyn A. Lamparelli MA 316978 Dejan Landup IL 314087 Christine F. Lang TX 316581 Corrine A. Larkai NY 318633 Dominique A. Lauten AK 318106 Megan Lawman SC 316528 Thuy Le PA 318114 Alexia Leal NM 71 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Comparison of the frequency of hypoglycemia in institutionalized patients on concomitant glipizide and selective‐serotonin reuptake inhibitor (SSRI) therapy versus glipizide therapy alone: a pilot study Appropriateness of stress ulcer prophylaxis therapy in the intensive care unit (ICU) with a pharmacist's intervention Outcomes associated with extended infusion piperacillin tazobactam in patients with Pseudomonas aeruginosa infection Assessing the effects of drug therapy management interventions on therapeutic change and glycemic control for type 2 diabetic patients in a Medicaid population Retrospective comparison of bleeding complications of 12 hour versus single vial infusion of eptifibatide and between eptifibatide versus bivalirudin in unstable angina (UA)/non ST‐
elevation myocardial infarction (NSTEMI) Implementation of a transition of care service for patients with congestive heart failure or atrial fibrillation in a two hundred fifty bed community hospital Optimizing intravenous drip concentrations and volumes for the pediatric population 9‐126 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐021 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐092 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐158 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐243 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐011 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐192 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. Incidence of sternal wound infections and the application of a topical antibiotic protocol in post cardiothoracic surgery 8‐166 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315628 Garrett Lech MA 316465 Kirsten Lechner DE 317212 Travis K. Ledford NC 317114 Catherine C. Lee PA 314509 Gina Lee VA 317160 Eun‐Young Lee MD 316536 Maxine Lee NY 318300 Jennifer Y Lee OH 72 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time patients 316606 Phillip H. Lee TN Extended‐infusion piperacillin‐tazobactam in a community hospital 8‐207 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317675 Natalie R. Lee TX 8‐288 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318445 Catherine Lee WA 9‐249 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318498 Jae Hun Lee WA Outcomes associated with markedly elevated lactate levels in the setting of normal central venous oxygen saturation following cardiac surgery Utilization of a standardized symptom assessment tool to detect hand‐foot syndrome toxicities in order to evaluate the relative effectiveness of celecoxib versus supportive care Lowering blood transfusion frequency by pharmacist managed anemia clinic 9‐251 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 315010 Christina Yon Lee FL 10‐059 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317032 Jamie H. Lee FL 10‐102 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318056 Chungeun Joanne Lee FL 10‐121 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318197 Kristina Lee FL 10‐128 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315550 Kasey Leggette TX 8‐246 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 73 | P a g e Impact of a clinical pharmacist inpatient medication counseling program on HCAHPS scores Evaluation of an epoetin alpha use and monitoring protocol in a tertiary care hospital Impact of pharmacist intervention in the management of breakthrough chemotherapy induced nausea and vomiting in an outpatient infusion center Impact of the pharmacist on an interdisciplinary heart failure (HF) team: a mixed methods approach Hospital readmission rates for alcohol detoxification in patients treated with long acting injectable naltrexone Submissi
on ID Primary Author Full Name State/ Country 316512 Caryn Lehmann WI 318324 Joseph Leiman MD 317241 Jona Lekura MI 315374 Jessica M Lemoine NC 317084 Jayme M. Lentz FL 318183 Sheri Leung CA 318632 Pamela Levine OR 317225 Kate M. Lewis NH 316560 Susan J. Lewis OH 312635 Shan Li PA 74 | P a g e Title Analysis of medication‐
related interventions by a pharmacist during hospital discharge in a Veterans Affairs Medical Center Utilization of tolvaptan for hyponatremia in hospitalized patients Evaluation of the effectiveness of a weight‐
based heparin dosing protocol in obese and underweight patients Comparison of intramuscular vitamin K versus oral vitamin K suspension and its affect on readmission rates in healthy infants Trimethoprim‐
sulfamethoxazole exposure and hyperkalemia in elderly Veterans receiving spironolactone Impact of intervention design on patient engagement in a pharmacist‐run asthma pilot Impact of antimicrobial stewardship programs at a health system Use of a fentanyl‐based protocol for early pain treatment in trauma patients The gender differences in virological outcome in HIV‐
infected patients on Highly Active Antiretroviral Therapy(HAART) Consequences of inappropriate usage of Lactobacillus: intended to protect, but can infect. Session/ Board Number Day Time 6‐268 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐019 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐061 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐066 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐103 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐045 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐108 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐059 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐120 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐112 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Assessment of adherence to dosing recommendations for indomethacin use for patent ductus arteriosus (PDA) closure in neonates Effects of Pharmaceutical Representatives on Prescribing Practices 7‐039 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐032 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐158 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐088 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐170 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐129 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐094 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐146 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐046 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐117 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316484 Amanda Li MO 316372 Tak Li CA 316334 Justin Liauw ME 317826 Tiffany Lin NJ 315168 Yi‐Cheng Lin MN 315548 McDonnell D Lindsay PA 318437 Sadie Linford MT 315597 Adam Linstedt IL 318413 Mario Listiawan CA 318542 Alice Shinyiing Liu ND 75 | P a g e Evaluating prescriber intimidation and safety culture at Maine Medical Center Correlation between proton pump inhibitor use and Clostridium difficile‐
associated diarrhea in a tertiary academic hospital Evaluation of tacrolimus utilization in kidney and heart transplant patients at a major metropolitan hospital Evaluation of the management of septic patients in the critical care unit Development a assessment of a pharmacist‐managed protocol for the adjustment of urinary tract infection empiric therapy Evaluation of sedative dose administered during day and night shifts in mechanically ventilated patients Evaluation of adverse drug reactions between subcutaneous and intravenous administration of bortezomib An evaluation of medication reconciliation with assessment of the pharmacists role upon patient admission to a tertiary care hospital Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Outcomes of ambulatory medication reconciliation in a geriatric patient‐centered medical home Development of a critical valproic acid concentration protocol. 8‐031 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐095 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315659 Victoria Liu MI 314468 Dazhi Liu OH 318224 Hannah J. Livengood DC Tracking patient specific information using MedEx technology 8‐013 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317945 Caren J. Liviskie MO 7‐054 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318058 Joe Llewellyn NM 7‐140 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317404 Sara K. Lookabill MI 8‐064 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318170 Tara Rae Lorenzi IL 10‐191 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318510 Stephen Lott MI 8‐086 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316276 Sara Low AK 6‐002 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318383 Celia Lu NY 7‐244 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315964 Wenya Lu TX Evaluation of an insulin therapy protocol for hyperglycemia in very low birth weight infants in a neonatal intensive care unit (NICU) Assessment of a hospital implemented dosing protocol for treatment of alcohol withdrawal Weight based dosing of tissue plasminogen activator (t‐PA) in the treatment of pulmonary embolism Implementation of the post acute support system (PASS) program to high‐risk Medicare beneficiaries Design, Implementation, and Assessment of a High‐
Touch Oral Oncolytic Nursing Adherence Program in a Specialty Pharmacy Implementation and evaluation of an integrated pharmacist in the Nuka model at the Valley Native Primary Care Center (VNPCC) Medication reconciliation and adherence in ambulatory care. Time is now, but how? Dose response retrospective study of omega‐3 fatty acids in the veteran population with very high 8‐249 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 76 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Retrospective review on the safety and compliance of intravenous iron replacement therapy using ferumoxytol versus ferric gluconate in adult patients with anemia and chronic kidney disease Development of Guidelines for Staffing Related Risk factors of Medication Errors 10‐240 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐103 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Impact of pharmacists on weight reduction in a community pharmacy based weight loss program Pharmacist impact on collaborative osteoporosis care for veterans at high fracture risk Tolvaptan Evaluation in an Academic Medical Center 8‐300 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐050 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐246 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐260 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐147 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐115 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐239 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. triglyceridemia 315170 Eging Lu LA 315424 Drew David Luder OH 318434 Vanessa Lujan TX 318514 Emily C. Luk CA 318467 Tara Lukawski NY 316636 Diana F. Luong TX 317933 Antonia Luu MA 316418 Jennifer Luxenburg OH 318273 Kathleen Lynch NY 77 | P a g e Evaluation of fluid resuscitation with crystalloid versus albumin in severe sepsis and septic shock in the cirrhotic population Implementation and results of a diabetic ketoacidosis protocol in a community hospital setting Evaluation of glycemic control in patients with type 2 diabetes changed from insulin glargine once daily dosing to twice daily dosing Cost and Safety Evaluation of Commercial versus Customized Parenteral Nutrition Products at a Community Teaching Hospital Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Procalcitonin to assist in antimicrobial stewardship in the septic patient 10‐155 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. Drug utilization study in patients with locally advanced breast cancer 6‐214 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Impact of the use of a sepsis screening tool on the initiation of antibiotic administration Use of a status epilepticus bundle to improve patient outcomes at a tertiary care center Evaluation of pharmacist‐
provided vs. physician‐
provided warfarin management of inpatient internal medicine and surgical patients in a Veterans Affairs medical center Correlation of nasal screening with culture results in critically ill patients suspected of having a methicillin resistant Staphylococcus aureus (MRSA) infection Evaluating efficacy of antimicrobial impregnated bone cement in primary total knee arthroplasty based on patient risk factors Review of monitoring parameters related to methotrexate's black box warning in outpatients at Alaska Native Medical Center (ANMC) Preventing hypoglycemia episodes with a pharmacy protocol for insulin order‐
verification in a community teaching hospital 8‐014 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐212 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐070 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐138 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐008 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐001 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐021 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316194 Neal T. Lyons IL 317429 Adela Madrid Spain 318443 Astra P. Mahabir DC 315784 Ahmed A. Mahmoud KY 314198 Melissa Mahoney IN 317655 Phil Maletich OH 316504 Kevin Malina AZ 315591 Madalene Mandap AK 318409 Claude Manjo MD 78 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 317962 Klara I. Manning PA Osteoporosis assessment in men in an internal medicine outpatient clinic 6‐177 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317461 Pablo March Spain 6‐219 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317942 Ruchit Marfatia MA 9‐148 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317417 Agullo Marine France 6‐021 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 312076 Roberto Marin‐
Gil SPAIN 6‐191 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317359 Bernard L. Marini MI 8‐063 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317432 Sarah Mark NY Colistine 0,1% cream in the treatment of PSEUDOMONAS AERUGINOSA MULTIRESISTANT (PAMR) Evaluating the effectiveness of a pharmacist‐managed vancomycin dosing and monitoring protocol in a community hospital setting Eculizumab and atypical hemolytic uremic syndrome in pediatric patients: new insights USTEKINUMAB, ADALIMUMAB AND ETANERCEPT: INDIRECT COMPARISON FOR EFFICACY IN MODERATE TO SEVERE PSORIASIS Risk of graft‐versus‐host disease with rituximab‐
containing conditioning regimens in allogeneic hematopoietic stem cell transplantation: a retrospective cohort study Medication use evaluation of levalbuterol at a large academic medical center 7‐212 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318143 Matthew J. Marston ME 9‐163 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318049 Jessica L. Martinez TX 8‐295 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316382 Aileen N. Martinez FL 10‐080 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 79 | P a g e Utility of Hemoglobin A1c Screening in Detecting Undiagnosed Diabetes Among Surgical Patients Transition to a six daily intravenous (IV) batch process at a pediatric teaching hospital and the associated cost savings. Evaluation of ceftaroline usage in a community‐based hospital Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day IL Comparison of extended infusion piperacillin‐
tazobactam versus traditionally dosed cefepime in patients with nosocomial pneumonia and susceptible pathogens Treatment with amphotericin B and mycafungin of an infant with candidal arthritis Medication use evaluation of intravenous immunoglobulin in inpatient and outpatient settings at an academic tertiary care center Utilization of linezolid at a large community hospital and a financial model analysis to evaluate current prescribing patterns versus proposed restricted use Antiepileptic drugs (AEDs) use evaluation of epilepsy patients attending neurology outpatient department of a tertiary care teaching hospital. Assessment and outcomes of an alcohol withdrawal treatment protocol with phenobarbital Reducing the use of linezolid and tigecycline through antimicrobial stewardship 10‐181 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐200 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐187 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐008 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐225 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐083 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐219 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Impact of multidisciplinary team efforts on the incidence of hospital‐
acquired Clostridium difficile infections in a community hospital Outcomes of piperacillin‐
tazobactam extended dosing compared to traditional dosing 7‐004 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐021 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317657 Melanie Martinez 316378 Belen Marzal‐
Alfaro 318272 Gerard P. Mascara PA 316883 Nicholas L. Massie AL 318357 Margarita Massot‐Cladera 316415 Jordan Masterson NC 317923 Julia Masterson TN 316157 Barbara E. Matike MD 315651 Christina Matsis CT 80 | P a g e Spain Spain Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Pharmacist interventions to improve provider adherence to the new hepatitis B vaccine recommendations for adults with diabetes Cardiovascular outcomes associated with the use of intravenous azithromycin and moxifloxacin Impact of selective serotonin reuptake inhibitor use on the effectiveness of clopidogrel therapy following coronary stent placement Evaluation of dual therapy on acetylcholinesterase inhibitors and anticholinergic medications Utilization of pharmacy services and evaluation of pharmacist workload before and after the implementation of computerized provider order entry in a hospital setting Achievement of sustained virologic response (SVR) and real‐world adherence rates in hepatitis C virus genotype 1 patients treated with telaprevir or boceprevir Evaluation of employee health plan utilization of esomeprazole 7‐271 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐220 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐277 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐039 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐278 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐228 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐144 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐051 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐190 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318171 Thomas Mina Matta OK 317693 Arun Mattappallil NY 317223 Alicia E. Mattson WI 316902 Mary S. Mavumkal CT 317335 Marion Max WI 315331 Anthony May UT 316513 Crystal D. Mayles‐Heise PA 317911 Andrew A. Mays MS 318123 Kyle Mays 81 | P a g e IL Implementation and evaluation of a pharmacist led employer sponsored diabetes management program in the employees of a rural medical center Implementing a pediatric pharmacy education program for new health‐
system pharmacists at a tertiary medical center with a non‐freestanding Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Comparative evaluation of weight based dosing of intravenous aminoglycosides among weight categories Comparison of INR control across the continuum of care before and after the implementation of computerized prescriber order entry (CPOE). Evaluation of bumetanide continuous infusion in pediatric patients 8‐305 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐009 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐192 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Comparative cost‐
effectiveness of alternative empiric antimicrobial treatment options for suspected enterococcal bacteremia Evaluation of ICU delirium pharmacotherapy after transition of care 8‐029 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐162 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐036 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐120 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐119 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐256 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. children's hospital 318477 Nolan J. McAfee TX 316612 Caitlin A. McBee AZ 315308 Katie McCallister TN 315434 Meghan N. McComb MI 318205 Taylor W. McConnell OH 315770 Amanda C. McDavid MI 315320 Alison McDonald PA 318136 Theresa McEvoy KS 314627 Kaitlin A. McGinn WV 82 | P a g e Predictors of vancomycin treatment failure for bacteremia caused by coagulase‐negative staphylococci (CoNS): a nested case‐control study Management of hyperglycemic crises at WellSpan Health System Evaluation of inpatient prescribing and monitoring of fentanyl transdermal system Evaluation of Continuous Subcutaneous Bupivacaine 0.5% after Cesarean Delivery Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Clinical relevance of time in therapeutic range: a comparison of usual care versus a pharmacotherapist‐
managed anticoagulation clinic Association between clinicians global assessment of functioning and serum 25(OH) vitamin D levels in adult veterans with schizophrenia residing in a long‐term care facility Assessment of the safety and effectiveness of dabigatran as an alternative to warfarin in the veteran population Identifying patient characteristics used to predict critically high serum vancomycin concentrations Evaluation of glucagon dosing at a tertiary care hospital 6‐261 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐163 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐178 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐270 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐097 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐052 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐141 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐181 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐148 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315417 Kayla M. McGowan WI 316271 Ian R. McGrane IL 316386 Christopher J. McGuire SC 318000 Michelle McIntyre WV 316807 Courtney McKay FL 317983 Jasmine S. McKee MS 317689 Christy McKenzie OH 318060 Jessica McKeon PA 317974 Charlie McKisson OH 83 | P a g e Analyzing the characteristics of a pharmacy associated with successful medication therapy management (MTM) programs: identifying drivers of success Red Blood Cell Length of Storage and Development of Deep Vein Thrombosis in Trauma Intensive Care Patients Ventricular assist device infection rate before and after a standardized surgical prophylaxis protocol Using anti‐factor Xa activity monitoring to evaluate therapeutic anticoagulation in renally insufficient patients receiving enoxaparin Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Evaluating the effectiveness of a pharmacy‐based renal dosing protocol on commonly ordered, inpatient medications. Inhaled epoprostenol in patients with acute respiratory distress syndrome and refractory hypoxemia Development and implementation of a pharmacist led medication reconciliation and discharge education program in a children's hospital Outcomes associated with reduced carbapenem use in patients with hematologic malignancies after the implementation of a febrile neutropenia clinical pathway Pharmacist in a Primary Care Healthcare Team in an Accountable Care Organization Type Model Impact of Patient Access to Free Nicotine Replacement Products on Smoking Cessation and Long‐Term Abstinence Recurrence rates of Clostridium difficile infection associated with a fidaxomicin‐containing treatment algorithm Initiation of pharmacist‐
driven discharge prescription reviews and interventions in the emergency department (ED): a pilot project Evaluation of vancomycin dosing weights in obese patients 7‐093 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐194 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐034 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐186 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐169 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐217 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐025 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐280 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐131 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317325 Christopher R. McKnight NC 316552 Megan McLaughlin NY 316584 Dayna McManus CT 318036 Michael L. McMillan IL 314578 Anusha McNamara MN 316357 Tracy McWhirter KY 311255 Saleha Hina Mehmood GA 317591 Ghazal Mehrdad WI 318262 Ryan E. Mejia FL 84 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Evaluating the impact of sepsis protocol implementation in the emergency department Use of ketamine for the treatment of depression in hospice‐care patients: a prospective, open‐label investigation Evaluation of therapeutic drug monitoring and dosing regimen adjustments in pediatric patients receiving intravenous vancomycin Vancomycin use in patients with ESRD receiving chronic intermittent hemodialysis: evaluating vancomycin clearance with high‐flux membrane dialysis Outcomes with antiepileptic drug use in post‐operative cardiac surgical pediatric and neonatal patients Prevalence of infective diagnoses in Ecuadorians less than 18 years of age: a result of environmental and socio‐economic influence? Recombinant factor VIIa utilization in pediatric critical care: medication use evaluation and guideline for appropriate use Pharmacists' Impact on HCAHPS Scores 7‐152 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐132 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐245 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐231 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐257 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐052 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐262 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐258 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐169 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐219 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 314487 Alla Melamed NY 317026 Amanda R. Melton NM 318422 Amanda K. Mercurio NY 318646 Joseph Merkel TN 316516 Mindl Messinger TX 318589 Vivian Metry CA 315512 Melissa Meuler WI 316556 Sarah Meyer TX 316965 Andrew D. Meyer IL 316398 Jennifer Meyer KY 85 | P a g e Delirium in the Pediatric Intensive Care Unit: Provider Perspectives Regarding Screening and Treatment Socioeconomic factors and the odds of receiving generic antiepileptic drugs Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 317442 Sara Jane Micale NY 7‐213 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316863 Emily Middleton OH 8‐127 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315946 Dana M. Mikrut IL 10‐152 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316563 Nick Milazzo CA 9‐033 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318469 Blake Miller MO 7‐062 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316211 Benjamin Blake B Miller NC 7‐074 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317948 Robert L. Miller NY 7‐229 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316335 Stacy Miller ME 9‐159 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317158 Jennifer L. Miller KY Effects of denosumab on bone mineral density in primary hyperparathyroid patients not receiving surgery Safety and efficacy of various antiretroviral regimens for the treatment of HIV in pregnant women: a retrospective review Descriptive report of off label use of recombinant factor VIIa in a community health system Matching Pharmacy Clinical Skill Sets with Appropriate Positions within the United States Air Force (USAF) Effects of order set use on the treatment of clostridium difficile: a best practice assessment Implementation and Evaluation of a Pharmacist‐
led Hypertension Management Service in a Collaborative Primary Care Setting. Treatment compliance in OEF/OIF veterans with PTSD treated at the PTSD Medication Management Clinic at the VAWNY Healthcare System Evaluation of a pharmacist driven bivalirudin dosing protocol for heparin induced thrombocytopenia (HIT) Retrospective study of 2007 Infectious Disease Society of America / American Thoracic Society minor criteria and intensive care unit admission process: impact on community acquired pneumonia 10‐227 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 86 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 318088 Vanessa E. Millisor PA State of South Carolina cumulative antibiogram project 6‐182 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317062 Alaa A. Minkara OH 8‐130 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316236 Leah H. Mitchell NC 7‐078 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318215 Lisa Modelevsky NY 7‐237 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317636 Mia Incaprera Monson LA 10‐245 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316644 Melinda Tara Feliz Montoya NM 7‐130 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317702 Donald C. Moore MA 9‐143 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317433 Geoffrey A. Morgan MI Evaluation of vitamin D level utilization and supplementation in chronic kidney disease patients at the Cincinnati Veteran Affairs Medical Center: a retrospective chart review analysis Evaluating patient education of warfarin therapy in pharmacist consulted anticoagulation management patients versus physician management patients at Forsyth Medical Center Incidence of clostridium difficile‐associated diarrhea at a community hospital in patients receiving a proton pump inhibitor or H2 receptor antagonist Measuring the impact of Lactobacillus rhamnosus GG on the rate of C. difficile associated diarrhea in ventilated patients in the adult intensive care units Continuous infusion (CI) vancomycin compared to intermittent vancomycin: a matched case series to evaluate time to therapeutic vancomycin level in critically ill patients Standardizing a clinical approach to antimicrobial de‐escalation in a community teaching hospital Automated venous thromboembolism risk assessment and its effect on patient prophylaxis 8‐066 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 87 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and Clopidogrel Evaluation of ceftriaxone for bacteremia due to Methicillin‐susceptible Staphylococcus aureus Developing an Adherence Pharmacology Complexity Metric for HIV Patients in an Urban Immunodeficiency Clinic Evaluation of risk factors for hip fractures in older adults: associations with potentially inappropriate medications for elders Opioid safety in hospitalized patients 8‐239 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐124 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐217 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐055 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐116 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Antibiotic selection, use and compliance to GOLD guidelines in the treatment of COPD exacerbation at ARH Medical Center, Hazard, KY. Assessing rates of venous thromboembolism in patients with impaired liver function who have an increased international normalized ratio (INR) Presence of potentially inappropriate medications in elderly outpatients of a veterans medical center using the screening tool of older persons prescription (STOPP) criteria Impact of state‐required controlled prescription database on prescribing practices in a community hospital emergency department 10‐236 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐311 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐180 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐220 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315350 Kathleen M. Morneau TX 316760 Geoffrey Mospan OH 317619 Amy Moss NY 318628 Sarah J. Moy CA 315164 Laura J. Muchesko PA 318148 Alem Mulat KY 318595 Christyn Mullen TX 316530 Mackenzie L. Mullenix SC 316454 Tara D. Mullins KY 88 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Evaluation of precursor adverse drug events and their correlation to adverse drug events resulting in patient harm. Evaluation of vancomycin dosing protocols in obese patients 8‐135 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐126 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐076 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐069 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐111 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐112 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐294 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐131 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐088 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317475 Kyle Mulloy OH 316799 Michelle E. Munch OH 316602 Nima Munir NJ 316136 Andrew R. Murgittroyd NJ 317578 Heather Murphy FL 317596 Kendrick C. Murphy FL 317926 Timothy F. Murrey TX 315767 Tara Muzyk PA 316614 Leena D Myran MT 89 | P a g e Retrospective analysis of cardiopulmonary arrest (CPA) events for the purpose of screening for the presence of QT prolonging medications and other risk factors Impact of pharmacist discharge counseling on thirty day readmission rates and HCAHPS scores with a focus on patients diagnosed with CHF, MI, or PNA Impact of an inpatient pharmacist managed warfarin service on patient safety in a community hospital setting Self‐titration of basal insulin: identifying barriers to patient adherence Evaluation of medication errors associated with human immunodeficiency virus (HIV) treatment in hospitalized patients Marketing a video teleconferencing counseling service to veterans and providers at community based outpatient clinics Effect of an electronic pathway driven protocol for the selection of antimicrobials in the treatment of sepsis at a community hospital Time Submissi
on ID Primary Author Full Name State/ Country 316273 Michelle Nadeau CT 317906 Farah Rose Namissa NJ 316517 Navaneeth Narayanan NJ 317629 Halil Tufan Nardali NC 317682 Layla Nashi NJ 315978 Kobi T Nathan NY 315524 Ravi Nehra PA 318025 Xiaoxue Nehrbass MD 316888 Elana M. Nelson MO 318185 Rebecca J Nelson FL 90 | P a g e Title Session/ Board Number Day Reducing 30‐day readmissions for chronic obstructive pulmonary disease: a pharmacist‐led multidisciplinary intervention Role of pharmacists in management of heart failure patients post‐
discharge Ibuprofen‐induced aseptic meningitis 10‐028 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐091 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐073 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Impact of a pharmacist in preparation for transitioning from charging for medications upon dispense to charging for medications upon administration in a community teaching hospital Risk factors for readmission due to Clostridium difficile infection 7‐098 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐084 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐170 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐127 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Medication use evaluation of bivalirudin in an academic medical center 7‐016 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. Evaluation of the impact of a medication assistance program (MAP) on hospital readmission rates Sargramostim versus filgrastim following induction chemotherapy in acute myeloid leukemia: a retrospective comparison of clinical outcomes 7‐043 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐127 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. Increasing risk awareness for Torsades de pointes: evaluating QTc prolonging medication use and monitoring in hospitalized patients Pharmacist‐facilitated discharge medication reconciliation Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day MO Evaluation of leflunomide for the treatment of BK viremia and biopsy proven BK nephropathy: a single center experience Evaluation of discharge prescribing patterns of antipsychotics for acute delirium in geriatric patients The effect of pharmacist‐
managed antimicrobial stewardship in an intensive care unit in a community hospital Evaluation of early intravenous to oral corticosteroid transition in acute management of chronic obstructive pulmonary disease exacerbation Symptom‐driven phenobarbital protocol for the treatment of alcohol withdrawal in the medical intensive care unit (MICU) Transitions of care: impact of pharmacist education in heart failure patients 7‐053 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐144 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐161 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐090 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐197 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐057 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐142 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐045 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐269 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐014 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317890 Nicole Nesselhauf 315592 Kelly N Nesseth IL 316254 Lisa L. Neyens IL 317876 Victor Ng NJ 316580 Kimberly Erin Ng NY 317176 Elaine Ng MI 315549 Clement E. Ng IL 317179 William Ngo MO 317936 Que‐Minh Ngo WV 317806 Michael Nguyen AZ 91 | P a g e Appropriateness of echinocandin empiric use and de‐escalation in a community health‐system. Evaluation of a therapeutic interchange from scheduled ipratropium to tiotropium in chronic obstructive pulmonary disease (COPD) Impact of pharmacist education on phytonadione utilization in a teaching hospital for warfarin reversal based on current clinical guidelines Evaluation of albuterol versus levalbuterol use for treatment of chronic obstructive pulmonary Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time disease and asthma in a community hospital 315478 Hien T. Nguyen NJ Inhaled amphotericin b for rhizopus 6‐065 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316534 Thom K Nguyen NJ 6‐074 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317389 Ruthie Nguyen OR 6‐103 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318069 Nhi C Nguyen VA 6‐255 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317700 Anny Nguyen MD 7‐015 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315531 Dzuan K. Nguyen TN Implementation of a revised patient home medication policy for inpatient use in a community teaching hospital Implementation of a pharmacist‐managed pre‐
discharge medication education program to reduce 30‐day pneumonia readmissions Pharmacist Intervention Impact on Clostridium Difficile Guideline Compliance A single‐center evaluation of the risk for colonization or infection with multidrug resistant (MDR) bacteria in patients with acute leukemia receiving fluoroquinolone prophylaxis Evaluation of order entry reports from a voluntary reporting system 8‐196 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316300 Jennifer T. Nguyen TX 8‐254 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316591 Veronica Nguyen TX 8‐259 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317340 Y‐Nha P Nguyen TX 8‐281 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 92 | P a g e Clinical impact of a pharmacist managed ambulatory care clinic on glycemic control at a Veterans Affairs Medical Center The Use of a FMEA to Proactively Identify Medication Errors with U‐20 insulin Validation of once‐daily tobramycin protocol for the treatment of pulmonary exacerbations in cystic fibrosis patients Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Improving post hospital transitions of care: a patient centered approach to medication reviews Implementation of pharmacist‐led disease state management clinics utilizing the clinical video tele‐health system (CVT) to expand health care access to Veterans at an outreach clinic Integrated hepatitis C treatment therapy approach in a Veterans Affairs Medical Center Distinguishing true bacteremia from culture contamination using procalcitonin Development and assessment of a chemotherapy preparation checklist using simulations Evaluation of the use of intravenous acetylcysteine for the treatment of acetaminophen poisoning Piperacillin/Tazobactam Medication Usage Evaluation 9‐040 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐197 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐198 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐248 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐118 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐156 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐162 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐037 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐054 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐193 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316786 Belinda Nguyen CA 317667 Thien Huong Nguyen NV 318237 Kim Chi Nguyen NV 318415 Phuong‐Lien Nguyen WA 317861 Kristy Nguyen FL 316202 Olivia H. Nguyen IL 317435 Jennifer Niccolai PA 316775 Kristina Niehoff CT 318616 Nooshin Niknam CA 316548 Orsika Niyzov NY 93 | P a g e Evaluating a pharmacist's training program to become a member of the cardiopulmonary resuscitation team Evaluation of intravenous acetaminophen use and associated outcomes in the gastro‐enteroplasty population Barriers to patient recruitment and attendance to outpatient clinic services at an inner‐city teaching hospital Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Single center analysis of effectiveness and cost of pre‐emptive or rescue plerixafor administration in patients with multiple myeloma and non‐Hodgkins lymphoma undergoing stem cell mobilization Comparison of clinical and analytical results obtained with two granulocyte colony stimulating factors in oncology patients with chemotherapy regimen composed by docetaxel, adriamycin and cyclophosphamide Evaluation of educational efforts to healthcare staff to decrease time to N‐
acetylcysteine administration in suspected acetaminophen overdose Development of a pharmacy student electronic health record webinar training program Evaluation of statin dose conversion and effect on discharge medications 7‐005 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐222 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐032 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐182 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐241 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Evaluation of withdrawal syndrome associated with dexmedetomidine in pediatric critical care patients Patient Assistance Programs: Co‐pay Driven Compliance 8‐214 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐013 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. Intraventricular hemorrhage prophylaxis with indomethacin in preterm very low birth weight neonatal intensive care unit patients and prevalence of clinically significant patent ductus arteriosus 7‐065 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316550 Carmen Nobre MD 317897 Maite Nogales Spain 316541 William Nolan CT 317846 Victoria E Noonkester IL 311508 Sarah C. Nordberg VA 317697 Johanna L. Norman TN 317958 Logan Norman AL 315258 Jennifer Ellen Norris NC 94 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 316351 Brett R Noteware TX Effects of prolonged infusion of meropenem on patient outcomes in the critically ill 8‐255 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317625 Natalie Noto MA 9‐141 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316255 Katherine M Nowicki KS 9‐106 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318080 Aliercy Nunez Sanchez FL 10‐123 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316200 Sidonie Nupa NC Hypoglycemic events in a veteran population presenting to the emergency department and urgent care: a descriptive analysis Incidence of postoperative atrial fibrillation in cardiac surgery patients sedated with dexmedetomidine versus propofol Effectiveness of a pharmacist providing patient‐tailored medication discharge counseling utilizing adherence tools The renal effects of vancomycin loading doses. 7‐072 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315483 Gift Nweke TX 8‐244 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318065 Tara Nygaard FL 10‐122 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315999 Bissy C Obi TX 8‐250 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317282 Macklin C O'Brien WA 9‐228 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317469 Colleen O'Brien 10‐179 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 95 | P a g e IL Quality assessment of the appropriate prophylactic dose of enoxaparin in underweight patients Therapeutic drug monitoring of gentamicin in neonates: appropriateness and cost savings Retrospective chart review of adverse drug events occurring in the emergency department at a community teaching hospital Application of the Pharmacy Practice Model Initiative (PPMI) in a 450‐bed community hospital A Retrospective Review of Appropriate Use of Glycoprotein IIb/IIIa Inhibitors and a Direct Thrombin Inhibitor at Northwestern Memorial Hospital Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Establishment and implementation of a cystic fibrosis medication management service in an academic medical center Impact of pharmacist oversight on linezolid use within a small post‐acute care hospital Utilization of prophylactic heparin vs. enoxaparin before and after initiation of pharmacist driven protocols for therapeutic interchange, discontinuation of venous thromboembolism (VTE) prophylaxis, and VTE order set changes. Impact of a novel staphylococcal bacteremia rapid diagnostic test on antimicrobial therapy at an academic medical center Implementation of a standardized and comprehensive policy for safe‐handling of hazardous drugs in a community teaching hospital Using lean six sigma methodology to improve vancomycin prescribing, dispensing, and monitoring at a tertiary care referral center Inpatient to primary care: evaluating the impact of a pharmacist in a post hospitalization follow up clinic for patients without primary care providers Medication review software to improve the accuracy of inpatient medication reconciliation: a descriptive study 6‐281 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐127 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐030 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐262 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐115 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐273 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐212 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐038 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317703 Jennifer O''Callaghan WI 316433 Daniel O'Connell NM 315808 Katie O'Dell MO 316702 Jazmine A. Okuboyejo TX 316033 Ayodele Olamijulo ND 316955 Debra A Oldanie WI 317695 Melissa M. Olson SD 316693 Lindsey Ong CA 96 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Outcomes and patient satisfaction with a pharmacist managed clinical video telemedicine (CVT) anticoagulation clinic Developing, implementing, and evaluating computer‐
based pharmacist competencies of chemotherapy complications Medication use evaluation of methadone in an academic medical center 7‐002 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐097 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐017 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. Retrospective analysis of a current heparin algorithm in obese patients and time to achieve therapeutic doses Expanding pharmacy resident research to include qualitative projects 8‐143 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐172 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. Impact of pharmacist‐led interventions to promote appropriate colchicine prescribing following FDA‐
labeling changes: a retrospective review The effect of oral vancomycin dose on outcome for the treatment of severe C. difficile associated diseases (CDAD) Evaluation of the appropriateness of stress ulcer prophylaxis before and after implementing hospital‐
wide stress ulcer prophylaxis guidelines at a university‐
based teaching hospital Comparison of rivaroxaban versus fondaparinux for postoperative thromboprophylaxis in patients undergoing hip or knee arthroplasty 7‐104 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐083 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐044 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐209 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 314183 Mallory Onisk MD 315776 Robert N Ono OR 318030 Paul Ortiz MD 317842 Kara Osterfeld OH 315731 Megan R. Ostrem MN 318070 Jared Ostroff NC 318294 Stacy A. Otremba MI 317136 Emily J. Owen MO 315464 Chelsea Owen KY 97 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Impact of procalcitonin level in a community hospitals antimicrobial stewardship program. Evaluation of the treatment of nosocomial pneumonia in a community hospital 9‐082 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐206 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Impact of extending hours of clinical pharmacy coverage at an academic medical center Influence of smoking status on time to discontinuation of duloxetine in patients with major depressive disorder (MDD) Implementation of computerized decision support and education for a HAP/VAP/HCAP treatment protocol in the ICU: effects on protocol adherence, patient outcomes, and antibiotic costs Cross‐sectional population based study examining the impact of children with asthma on US rural versus non‐rural families Root cause analysis for 30 day readmission following kidney transplantation 9‐231 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐097 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐104 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐167 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐074 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐211 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐101 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐066 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316312 Alexandria Padgett IN 316565 Lesley Pahs TN 317411 Grace H. Pak WA 314622 Emma C. Palmer OH 317927 Mary Palmquist OR 314294 Laura Claire Palombi MN 318051 Alison Palumbo MI 315699 Anne Parada KY 317000 Joseph S. Pardo FL 315598 Simran K. Parihar NJ 98 | P a g e Implementation of a screening tool to assess pharmacist intervention on deprescribing in the geriatric population Searching for the optimal colistin dose: experience within a community health system Fecal transplantation in recurrent clostridium difficile infection Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Current trend in the prevention of myocardial infarction and stroke in Human Immunodeficiency Virus (HIV) patients Preventing readmissions of poorly compliant diabetic ketoacidosis and hyperglycemic hyperosmolar state patients using a team approach Pharmacists response to drug‐drug interaction alerts: impact on alert fatigue as a result of reducing non‐
clinically significant interactions Evaluation of treatment concordance with clinical practice guidelines for Clostridium difficile infection (CDI) in a community hospital Implementation of a pharmacist run transition of care heart failure clinic 7‐250 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐026 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐129 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐137 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐087 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐211 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐146 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐015 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318592 Tae E Park NY 315016 Diana Park CA 318231 Crystal Parke FL 316158 Justine M. Parker PA 316723 Zackery O Parker NC 317388 Michael A. Parker NY 317921 Katelyn A. Parsons MA 318076 Julia E. Pate AL 99 | P a g e Identifying opportunities for expansion of the MedSense program; evaluating disparities in standards of care and medication‐related problems in Lifetime Health centers lacking a MedSense program Effect of conversion from separate corticosteroid and long‐acting beta agonist inhalers to a combination inhaler on chronic obstructive pulmonary disease exacerbation rates: a pilot study Evaluation of a standardized vancomycin dosing protocol for hemodialysis patients to achieve therapeutic serum concentrations Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Variation of CHADS2 vs. CHA2DS2‐VASc in Administration vs. Chart Review to determine the true overall risk scores for patients with Atrial Fibrillation in the intermediate risk score Evaluation of adherence to antiviral medications in the treatment of Hepatitis B 6‐028 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐029 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 315638 Amit B Patel GA 315676 Neelam B. Patel GA 316502 Amit Ramesh Patel NJ Evaluation of the efficacy, dosing and safety of recombinant factor VIIa 6‐072 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317807 Deval Patel NJ 6‐087 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318119 Jenica Patel VA Evaluation of Route of Administration of Epinephrine for Safety & Efficacy (ERASE) Impact of a pharmacist encounter on medication‐
related patient satisfaction 6‐256 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316958 Keta Patel DE 8‐022 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315313 Sonal Patel MI 8‐025 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317614 Rupal K. Patel OH 8‐136 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318561 Yogin Patel TX 8‐309 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316217 Pinal Patel FL 10‐077 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 100 | P a g e Comparison of dabigatran and warfarin in patient status post coronary artery bypass graft surgery. Epidemiology of vancomycin‐resistant enterococcus isolation in orthotopic liver transplant recipients Using active methicillin resistant staphylococcus aureus (MRSA) surveillance nasal swabs to predict clinical respiratory cultures at the Cincinnati Veterans Affairs Medical Center Low dose glucarpidase in combination with hemodialysis in a patient with impaired methotrexate clearance Pharmacist managed telephone follow up clinic in Veterans Health Administration Submissi
on ID Primary Author Full Name State/ Country 318162 Rusha Patel FL 317148 Irasema Paul UT 318103 Shilpa Paul CT 316482 Kathryn Pauley MO 317805 Sarah J. Payne OK 316833 Khayla Payton AL 314293 Kathryn J Pederson MN 317069 stefanie peeples MI 317445 Jason Pelletier MO 101 | P a g e Title Session/ Board Number Day Retrospective analysis to determine the incidence of acute kidney injury in patients treated with piperacillin‐tazobactam, vancomycin or the combination Predictive monitoring of zinc, copper, manganese, selenium, and iodine to maintain serum concentrations in parenterally fed pediatric patients Identifying and minimizing patient barriers to pneumococcal vaccination 10‐126 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐238 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐047 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. Characterization of administration of first dose antibiotics at Children's Mercy Hospital Evaluation and implementation of a multi‐
dose medication dispensing at discharge policy and procedure Retrospective review of Clostridium difficile infection at a community teaching hospital Cross‐sectional population‐
based study using Behavioral Risk Factor Surveillance Survey (BRFSS) to ascertain the characteristics of US rural adults with mental health concerns who experience stigma as a barrier to seeking care Pharmacy involvement in effective transitions of care 7‐038 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐264 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐007 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐166 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐055 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐050 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. Evaluation of the appropriate use of vitamin K as defined by the ninth edition of the American Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 6‐060 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐062 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐192 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐057 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐018 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐061 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐151 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐286 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐157 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐189 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. College of Chest Physicians antithrombotic guidelines 317878 Erin Pepin NH 316627 Kelly M. Percival IA 312711 Maria Antonia Perez Spain 315632 Laura J. Perry NH 316145 Michael N Perza DE 316416 Michael Peters IA 317984 Brad R. Petersen OH 318470 Evan T. Petrie WI 316212 Josie E. Petty IL 316486 Vincent Peyko NY 102 | P a g e Pharmacist‐driven non‐
formulary medication interventions: impact on staff time Utilizing procalcitonin levels to augment a pharmacist driven antimicrobial stewardship program SYSTEMATIC REVIEW OF EFFICACY AND SAFETY OF PEMETREXED IN NON‐
SMALL‐CELL LUNG CANCER Fixed dose rasburicase for the prevention and treatment of tumor lysis syndrome at an academic medical center Suspected tricyclic antidepressant (TCA) overdose successfully treated with lipids Implementation of a pharmacist managed vancomycin consult service: a three month pilot Comparison of current pharmacy directors career paths and perceptions of advanced degrees Evaluation of a basal‐bolus insulin protocol for continued dosing efficacy and safety optimization in non‐critically ill patients Evaluation of stress ulcer prophylaxis use in critically ill patients Evaluation of Clinical Improvement and 30‐Day Mortality in Patients with Isolated Bloodstream or Respiratory Tract Infections Caused by Community‐
Associated Methicillin‐
Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 8‐265 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐057 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐233 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐250 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐262 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐274 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐296 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐230 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐282 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Resistant Staphylococcus aureus (CA‐MRSA) 316855 Anjulie Pham TX 318581 Kaylyn Pham CA 317535 Christine Pham WA 318464 Ngoc‐Diep Pham WA 317047 Yvonne L. Phan OK 317190 Yen Thanh Phan TX 318066 Kady Phe TX 317952 Christina Phelan NY 317362 Achsah Samuel Philip TX 103 | P a g e Impact of pharmacist intervention on the appropriate use of stress ulcer prophylaxis in general medicine patients 24 Month Data Analysis: Impact of a Collaborative Practice Protocol For Diabetes Management on an HMO Medical Group/IPA Practice Model Population Analysis on the impact of a pharmacy‐driven protocol using procalcitonin levels for antimicrobial therapy optimization Transition of care: implementation of a multidisciplinary approach for electronic medication review in the emergency department Impact of new oral anticoagulants on rate of prescribing in non‐valvular atrial fibrillation patients for prevention of stroke and systemic embolism Patients perception of a community pharmacist managed hypertension service Evaluating the incidence of nephrotoxicity associated with the use of colistimethate at a large tertiary hospital Medication reconciliaion for children with medical complexity: a pharmacy‐
primary care collaborative Impact of clinical pharmacy service on pediatric asthma control Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Evaluation of clinical outcomes following conversion to extended infusion piperacillin tazobactam Cost benefit analysis comparing rivaroxaban and warfarin in post orthopedic surgery Reducing hospital readmissions: a pilot study of pharmacists' role on an American Indian reservation Clinical presentation and outcomes of patients bacteremic with ceftriaxone non‐susceptible versus ceftriaxone susceptible methicillin‐sensitive Staphylococcus aureus Clostridium difficile infection: evaluation of guideline based treatment, concomitant acid suppressing therapy, and cost in a veteran population Evaluation of patient education regarding acetaminophen daily dose limits in an internal medicine urgent care clinic Impact of pharmacist discharge counseling and medication reconciliation on readmission rates for patients with pneumonia Implementation and evaluation of a clinical video telehealth clinic for diabetes management Evaluating human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), highly active antiretroviral therapy (HAART) and in‐home HIV test knowledge: a survey of New Mexico pharmacists 6‐026 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐222 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐221 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐150 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐013 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐134 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐283 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐085 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐129 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 311588 Janise Phillips GA 316016 Kathleen T. Phu WA 316015 Jonathan David Phung WA 316773 Aaron Pickering PA 317305 Sarah A. Pierce MD 318404 Danielle C. Pierini FL 318117 Nicole Piette WI 316422 Natalie Pike FL 316622 Larry J Pineda 104 | P a g e NM Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 318031 Jordan D Pleskow NY 7‐232 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316438 Abigail Plummer FL 10‐086 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315642 Elisabeth Plunkett CA 9‐028 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316912 Natasa Popovic MA 9‐134 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317586 Jessica Porter NC 7‐097 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316471 Savannah K Posey LA 10‐244 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317172 Alicia N. Potter TN Procalcitonin as an adjunct biomarker for initiation and discontinuation of antibiotics in orthopedic patients Design and implementation of a targeted approach and pharmacist‐assisted medication reconciliation at hospital admission Evaluation of new vasopressor recommendations for septic shock in critically ill patients Effects of body weight on frequency of early discontinuation of dabigatran vs. warfarin for atrial fibrillation; a pilot study. Initiation of a warfarin transition tool to improve communication at hospital discharge Evaluation of appropriate use of eptifibatide (Integrilin) in patients being treated at St. Dominic Hospital for an acute myocardial infarction Retrospective analysis of antiplatelet therapy used in intracranial stenting 8‐212 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 311910 Tenley Poulin PA 6‐111 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 315349 Annie Pounders MO 7‐029 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316159 Cristofer Price KY 10‐215 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 105 | P a g e Quality improvement initiatives focused on enhancing customer service in the outpatient pharmacy at a veterans medical center Development and implementation of a pharmacist‐driven protocol for the discontinuation of inappropriate stress ulcer prophylaxis. Awareness, knowledge, and use of electronic nicotine delivery systems in a veteran population Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Vancomycin‐resistant enterococci (VRE) colonization and applicability in patients with intra‐abdominal infections Clinical practice model integration and formulary standardization of a community hospital and an academic medical center: days one to one hundred Impact of implementing Confusion Assessment Method in Intensive Care Units (CAM‐ICU) scores on delirium management in three intensive care units Evaluation of pharmacist initiated phone interview counseling program of patients taking oral chemotherapy agents from the Zangmeister Center Pharmacist collected medication histories in an observation unit 8‐306 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐031 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐042 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐161 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐075 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐160 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐175 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐179 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐047 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318515 Jaclyn K Priest TX 316532 David Pritchard IX CT 316835 Lanae Pritchett MO 318201 Jessica Pritt OH 316566 Gabrielle Lynn Procopio NJ 318181 Kristin Prox OH 317197 Pavel Prusakov IL 316421 Jennifer Pruskowski SC 317365 Spencer E Pummel MO 106 | P a g e Preventing surgical site infections: emphasis on antimicrobial prophylaxis and detection of methicillin‐
resistant Staphylococcus aureus nasal carriers Monitoring Voriconazole Levels in Immunocompromised Children Development of an antibiogram in a Veterans Affairs community Comparison of intravenous iron sucrose prescribing before and after the implementation of a mandatory order set across an 11 hospital health system Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Retrospective analysis of automated dispensing cabinet overrides of high‐
alert medications in the emergency department. A retrospective comparison of bupivacaine with fentanyl versus ropivacaine with fentanyl for labor analgesia Efficacy of vancomycin loading doses in critically ill patients with methicillin‐
resistant Staphylococcus aureus (MRSA) Aspirin Use and Intraoperative Bleeding In High‐risk Surgeries 6‐149 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐163 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐232 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐064 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316747 Sarah K. Pupo PA 318218 Maria Putrino OH 316196 Leah Quealy UT 315435 Peter Rabbath FL 317256 Ronnie Lee Rael NM Implementation of an inpatient warfarin protocol 7‐134 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317351 Amneet S Rai CA 9‐044 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 315652 Deborah Raithel IL 10‐147 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317236 Meenakshi Ravindran Ramanathan TX 8‐275 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317970 Muamer Ramic CT 10‐045 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315583 Sadaf Raminfar NY Analysis of Ribavirin Dose Reduction on Hepatitis C Patients Receiving Direct Acting Antivirals Neonatal indomethacin for prevention of intraventricular hemorrhage: a study of plasma concentrations, pharmacogenomic factors, and outcomes Comparison of a two‐step algorithm versus polymerase chain reaction (PCR) testing for the detection of Clostridium difficile infection in an academic, non‐profit, multi‐
hospital health system Analysis of risk factors that may contribute to readmission with a warfarin related adverse event Impact of pharmacist driven patient discharge counseling on Hospital Consumer Assessment of Healthcare 7‐159 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 107 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 7‐235 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐226 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐238 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐029 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐002 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐145 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐163 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐205 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. Providers and Systems (HCAHPS) scores: targeting a unit in need of improvement 318078 Monica Ramirez NY 316852 Lourdes Ramos KY 317910 A. Marie Rapier WA 316345 Stephen Rappaport CT 315690 Ashley E Rather AL 312276 Mohammad A. Rattu NY 317438 Brett A Read PA 315353 Drew Redden KY 108 | P a g e Comparison of two dosing regimens of subcutaneous unfractionated heparin for venous thromboembolism (VTE) prophylaxis in cardiac surgery patients Weekly versus daily dosing of azithromycin for the prevention of Mycobacterium avium complex in patients with acquired immunodeficiency syndrome Implementation and evaluation of an extended‐
infusion protocol for piperacillin‐tazobactam at a tertiary medical center Evaluation of a pilot pharmacy service across transitions of care to reduce 30‐day postdischarge healthcare utilization rates in patients with pneumonia or COPD exacerbation Evaluation of the appropriateness of parenteral nutrition therapy in adult patients at a large community hospital Evaluation of chronic oral phenytoin therapy and its effects on serum calcium and vitamin D levels at a Veterans Affairs Medical Center Specialty medication management clinic: A pilot clinic Vancomycin dosing in the obese adult population at a community hospital Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 315411 Melissa Rees WA Pediatric Voriconazole Dosing 9‐217 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316802 Karen M. Reeves FL 10‐096 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318033 Julia L Reffert OK 7‐267 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315385 Sergio Alejandro Regalado TX 8‐242 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317898 Rebecca B. Regen TN 8‐217 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315742 Sloan M. Regen TX 8‐248 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316220 Jacob Reichert PA 6‐140 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316558 Travis Reinaker PA 6‐146 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316330 TrisAnn Rendulic MI 8‐043 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316582 Stephen Rettig CA Computerized prescriber order entry (CPOE) patch removal order set at Miami VA Healthcare System Design of an evaluation of the risk for upper extremity deep vein thrombosis in patients with peripherally inserted central catheters Comparison of bleeding events while on warfarin versus dabigatran in veterans with atrial fibrillation Evaluation of the incidence of vancomycin treatment failure in pediatric patients with methicillin resistant Staphylococcus aureus bacteremia Comparison of venous thromboembolism prophylaxis compliance rates before and after the implementation of a venous thromboembolism order set among medically ill patients Verification of a new weight‐based heparin dosing protocol, a medication use evaluation Impact of pharmacist education on sedation practice in a trauma intensive care unit Outcome review of antibody mediated rejection treatment protocol in adult kidney transplant patients Appropriate antibiotic therapy for ventilator associated pneumonia (VAP) in the trauma intensive care unit of a level I trauma center 9‐036 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 109 | P a g e Submissi
on ID Primary Author Full Name State/ Country 317803 Michelle Rey 316851 Almudena Ribed 317947 Terran M Rice PA 316872 Kelvin Richards AZ 317436 Sara K. Richter MO 317134 Jamie Rickards SC 316936 Brenda Riesenberg IA 317831 Jessica M Rimsans MA 316904 Tanner Ringley NC 316225 Marieli Rivera Cruz NY 110 | P a g e NJ Spain Title Session/ Board Number Day Time Impact of increased pharmacist involvement in an outpatient anticoagulation clinic Nutritional status assessment in patients treated with oral chemotherapy Evaluation of vancomycin model range at York Hospital 6‐086 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐204 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐176 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Evaluating rates of appropriate venous thromboembolism prophylaxis and clinical outcomes according to meaningful use criteria with computerized physician order entry as compared with hand written orders. Evaluation of N‐
acetylcysteine for the prevention of contrast‐
induced nephropathy Significance of simvastatin dose adjustments due to drug interactions in a Veterans Affairs community Development and implementation of a tech‐
check‐tech program in a community hospital pharmacy Incidence and management of major bleeding in elderly patients initiated on dabigatran Development of a risk stratification system for prediction of recurrent clostridium difficile infection (R‐CDI) from patient specific variables Evaluation of albumin usage at a teaching institution 6‐011 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐049 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐182 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐063 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐145 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐090 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐177 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 318022 Daniela Roberts NM Antibiotic administration time in sepsis and corresponding survival 7‐139 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 314508 Ali B. Roberts TN 8‐189 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317943 Aundrea Robertson PA 6‐175 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 314632 Alyssa Robertson VA 6‐244 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 315939 Rashanda S. Robertson SC Analysis of Fosfomycin therapy in extended spectrum beta‐lactamase producing cystitis Evaluation of the use of calcium in the emergency department for patients with hyperkalemia Evaluation of glucose control in a community hospital on a general medicine floor Evaluating Neonatal Abstinence Syndrome Therapy within the NICU 8‐176 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316999 Jimenez‐Galan Rocio 6‐209 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 312269 Erin Rodems MD 7‐001 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316867 Erin Meghan Rogozinski MI 8‐051 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318157 Kiri M. Rolek PA National survey of aminoglycoside use in critically ill patients 6‐184 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316768 Theresa A Romaldini CO 10‐012 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316714 Vanessa Romero Diaz‐Maroto Implementation of a procalcitonin algorithm for guiding antibiotic therapy in patients with sepsis Adherence to entecavir for chronic hepatitis b in clinical practice and correlation with efficacy 6‐202 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 111 | P a g e Spain Spain Antiviral regimen complexity index as an independent predictor of sustained virologic response (SVR) in patients with chronic hepatitis C Characterization of anemia and its treatment in cirrhotics treated with boceprevir or telaprevir triple therapy Comparison of mannitol and hypertonic saline for intracranial hypertension Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Improving pharmaceutical care of the critically ill obese pediatric patient: a collaborative quality improvement (QI) project at Children's Hospital Colorado Evaluation and optimization of current aminoglycoside dosing practices in a neonatal intensive care unit Time to initial antimicrobial administration: a process improvement evaluation 10‐006 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐049 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐176 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐078 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐060 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐054 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐207 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐131 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐082 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐046 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316268 Emma L Ross CO 318348 Meghan M Rowcliffe CT 316500 Gina E. Rozinka MN 318116 Michael Rudoni MI 316072 Megan Rae Rustad IA 317022 Samira Saad MI 315993 Alexandra K Saastad SD 316690 Josie Saldana NM 318281 Jowan R. Salem MI 318527 Mohamed Said Sallout ID 112 | P a g e Evaluation of dexmedetomidine use in a tertiary, level I trauma institution Prescribing practices of medications requiring renal dose adjustments in a Veterans Affairs ambulatory clinic The Effectiveness of a Dosing Policy Guideline for Continuous Renal Replacement Therapy (CRRT) Patients across Intensive Care Units at Henry Ford Hospital Pharmacists' utilization of the 4Ts scoring system to predict heparin‐induced thrombocytopenia Antibiotic stewardship team (AST) initiative to decrease antibiotic days of therapy (DOT) and length of stay (LOS) utilizing NAAT based respiratory viral panel. Misuse it, you lose it: an assessment of the appropriate use of cefepime Implementation of basal/bolus insulin protocol in a rural hospital for hyperglycemia control in non‐critically ill inpatient Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time adult patients 315943 Dominick Salvatore MO Analysis of Adherence to Patient Controlled Analgesia (PCA) Basal Rate Policy 7‐032 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316339 Joseph Samide NY A Retrospective Evaluation of Stress Ulcer Prophylaxis in the Intensive Care Unit 7‐180 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317538 Lindsay N Samuel DC 8‐011 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316242 Erin N. Samuelson TX 8‐252 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 312261 Jamie L. Sanders OH 8‐173 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316857 Adrian Sandoval TX 8‐266 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315660 Erin Santiago NE 7‐121 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316270 Marina Sapozhnikova IN 9‐080 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318125 Kathleen M. Sargent MA Justification for a pharmacist led medication transitional care program at discharge for orthopedic patients in long term care Comparison of the efficacy of nimodipine in subarachnoid hemorrhage patients when treated for less than 21 days versus the standard of care with 21 days of therapy. Characterizing the Rate of Anemia Associated with NS3/4A Protease Inhibitors Used in the Treatment of Chronic Hepatitis C (HCV) Genotype 1 Evaluation of impact of targeted interventions on the use of high‐risk medications in the elderly Timeline analysis of initial antimicrobial order to administration in adult patients with sepsis throughout a community health system Emerging anticoagulants and their bleeding complications: an observational study at a community teaching hospital. Ticagrelor usage in patients at one leading cardiac care institution 9‐152 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 113 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Evaluation of empiric antibiotic coverage for hospital acquired pneumonia based on local microbiologic data Evaluation of the use of cinacalcet hydrochloride and its effects on intact parathyroid hormone levels in end‐stage renal disease patients Conversion from 5 percent albumin to 6 percent hydroxyethyl starch 130/0.4 in normal saline for volume resuscitation in cardiovascular surgery patients Effect of pharmacist medication reconciliation on appropriate psychiatric medication use EVALUATION OF CURRENT GRAM‐POSITIVE MICROBIOLOGICAL SUSCEPTIBILITIES FOR NOSOCOMIAL PNEUMONIA STRATIFIED BY DAY OF ONSET WITH EVALUATION OF PREVALENCE OF INSTITUTION‐SPECIFIC PATIENT RISK FACTORS FOR MULTI‐DRUG RESISTANT PATHOGENS. Impact of rocuronium administration on time to target temperature in patients treated with therapeutic hypothermia post‐cardiac arrest Implementation of a cardiovascular risk reduction service in a diabetes clinic 9‐201 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐161 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐010 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐269 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐175 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐142 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐096 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐052 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318427 Matthew Sasaki NV 315643 Josephine Sasu‐
Tenkoramaa NY 317451 Adam Joshua Sawyer AL 317078 Kendra J. Saxvik TX 315564 Mike Scalese SC 317694 Jenna L. Schaffner OH 314489 Laura Schalliol OH 318485 Amanda Schartel CT 114 | P a g e Comparison of patient satisfaction between telephone and point‐of‐care methodologies in a VA Anticoagulation Clinic Time Submissi
on ID Primary Author Full Name State/ Country 315470 Phillipa Scheele MA 316983 Martine Schiffer IL 317882 Michael D Schmidt MO 315807 Jessica S. Schnur VA 316991 Kevin W. Schoeffel WI 315774 Andrew Schoof OH 317891 Jennifer E Schriber WV 316968 Amy E. Schultz AL 316956 Nicholas A Sciacca IN 317647 Megan Sculley PA 115 | P a g e Title Implementation of a protocol to improve care transitions for patients recently discharged to the community from the hospital. Evaluation of nursing compliance to general medicine insulin correction table Evaluating the use of dexmedetomidine for sedation in a university medical center Evaluation of use of ticagrelor at a large community hospital Clinical outcomes of a pharmacist‐managed vancomycin dosing service in outpatients receiving intermittent hemodialysis Evaluating the clinical and financial impact of clinical pharmacy services on depressed patients in a safety‐net health center. Implementation of a pediatric bronchiolitis protocol and its impact on patient care The "Got Stent" campaign: An education program implemented by pharmacy to improve drug utilization post percutaneous coronary intervention Use of Activated Recombinant Factor VII (rFVIIa) in Adult Cardiothoracic Surgery Development and implementation of an antimicrobial stewardship program (ASP) at the Lebanon Veterans Affairs Medical Center (VAMC) Session/ Board Number Day Time 9‐123 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐171 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐052 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐247 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐274 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐105 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐268 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐009 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐090 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐169 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 315527 Rebekah K. Seale FL 10‐065 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317650 Eve‐Michelle M Segal ID 6‐043 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318384 Celeste A. Sejnowski PA 6‐188 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317835 Ben Selph GA 6‐039 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 315473 Eric J. Selvage PA Impact of a pharmacist directed antimicrobial stewardship program on the management of urinary tract infections Evaluating the benefit and safety of dose rounding cytotoxic and biologic medication to the nearest vial size Classification of inpatient adverse drug reactions leading to intensive care unit admission Establishing a pharmacist‐
led heart failure clinic to prevent hospitalizations at a Veterans Affairs Medical Center Methylnaltrexone bromide: a medication‐use evaluation 6‐124 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316510 Lisa Semancik CT 10‐030 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316997 See‐ Won Seo NJ 6‐080 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316710 See‐Won Seo NC 7‐112 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316821 David A Sergeant TX 8‐263 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318612 Michael Shaaw DC Impact of discharge counseling about cardiology medications on the Hospital Consumer Assessment of Healthcare Providers and Systems scores Implementation of a pharmacy‐driven medication occurrence reporting service: development of the service and preliminary data Impact of pharmacist interventions on reducing readmissions in asthma patients Pilot study and comparison of pharmacist‐managed warfarin consult versus physician‐managed anticoagulation Efficacy of a ketogenic diet alert warning system in a pediatric institution: a retrospective study 8‐017 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 116 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 318623 Dwight W. Shafer NE 7‐125 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318640 Amber Shaffer TN 8‐230 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317291 Milisha Shah NJ 6‐081 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316894 Neil Sandip Shah NC 7‐089 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316522 Priya Shah IL Evaluation of aminoglycoside (gentamicin and tobramycin) use, dosing method, and monitoring in an academic medical center versus a private institution Pharmacokinetic monitoring of vancomycin: correlation between target trough concentrations and the ratio of area under the curve to minimum inhibitory concentration Evaluation of fixed‐dose versus weight‐based dosing of morphine sulfate for the management of neonatal abstinence syndrome (NAS): review of an institutional protocol Medication treatment history and antipsychotic prescribing in children with attention deficit hyperactivity disorder (ADHD) enrolled in the state of North Carolina Medicaid program Mannitol use and evaluation in patients with brain injuries 10‐166 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318341 Punit J. Shah IL 10‐198 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317383 Raisa Shaikh FL 10‐110 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 117 | P a g e Implementation of a pharmacy‐integrated outpatient parenteral antimicrobial therapy (OPAT) service at a community hospital To evaluate the use of anticoagulants and the rate of venous thromboembolism (VTE) in patients undergoing total hip replacement (THR) and total knee replacement (TKR) surgery Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Prescribing patterns of intravenous acetaminophen in an academic teaching institution after implementation of computerized physician order entry Effect of co‐administered proton‐pump inhibitors on high‐dose methotrexate clearance in patients diagnosed with acute lymphoblastic leukemia or highly aggressive non‐
Hodgkin's lymphoma Immunization impact project: an interdisciplinary approach to improving inpatient immunization rates Single versus dual antiplatelet therapy after coronary artery bypass graft surgery Management of procedural and post‐surgical pain in the neonatal intensive care unit 10‐007 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐242 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐158 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐218 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐222 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐234 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐228 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐063 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐142 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316376 Courtney Shakowski CO 315786 Caitlin L Shamroe LA 316229 Colleen Sheehan IL 316369 Ryan Shely KY 317714 Mark Shen NY 318075 Germin Shenoda Fahim NY 317215 Megan Riddle Shepherd KY 315363 Veronica Sherman FL 318249 Jillian Sherrod 118 | P a g e NM Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a community‐
teaching hospital Evaluation of a pharmacist‐
managed heart failure education project: empowering patients to self manage their disease Review of albumin use and development of albumin prescribing criteria to optimize its use in a community hospital Cost Comparison of Parenteral Nutrition Compounding Processes Time Submissi
on ID Primary Author Full Name State/ Country 317421 Terri Lynn Shigle PA 314518 Alexandra Shillingburg WV 318611 Karen Shin NY 316682 Soo Young Shin IL 317931 Brittney Shippee AL 316562 Anna Shmayenik NY 318516 Raelene Marie Showery TX 317824 Lauren Shreckengosh KS 316134 Andrew Shulan OH 119 | P a g e Title Session/ Board Number Day Time Evaluation of nursing education on heparin protocol compliance 6‐161 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. Aprepitant and fosaprepitant use in children and adolescents at an academic medical center Influence of Race and Gender on Trough Concentration of Mychophenolic Acid, Its Glucuronidated Metabolite (MPAG) and GI Adverse Effects in Stable Renal Transplant Patients Receiving Enteric Coated Mycophenolate Sodium. Use of heparin in obese patients 9‐271 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐251 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐168 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. Retrospective, observational analysis of fidaxomicin versus vancomycin use and outcomes in the treatment of Clostridium difficile infections Evaluating adverse drug reactions leading to emergency department visits Post discharge pharmacist led medication therapy management (MTM) services for medically indigent patients with heart failure IV acetaminophen efficacy in gastric bypass surgery 9‐012 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐196 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐307 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐114 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. Evaluation of the appropriateness of medication management in patients diagnosed with Peripheral Arterial Disease (PAD) at the Cincinnati VA Medical Center (CVAMC) 8‐109 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 318009 Ashley Shumaker OH 8‐153 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316266 Michael D. Shuman IL 10‐162 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316650 Kristina Shvets CT 10‐035 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316555 Moe Shwin FL Evaluation of a defined‐
frequency, weight‐based vancomycin dosing guideline in hemodialysis patients Evaluating the treatment of borderline personality disorder in light of comorbid psychiatric conditions: focus on bipolar disorder Impact of follow‐up discharge phone calls for patients discharged on anticoagulant therapy Retrospective review of darbepoetin use in a community hospital 10‐089 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 314095 Grace I. Shyh NY 7‐149 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 314199 Tahmeena Siddiqui WI 6‐259 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317023 Eric F Sidman NY 7‐205 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 311253 Laura A. Siemianowski PA 6‐109 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316022 Francislene Silva 6‐017 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 314216 David R. Simmons 9‐164 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 120 | P a g e Brazil MN Antifungal prophylaxis in liver transplant recipients: risk factors and management Defining the elements of an antimicrobial stewardship program for a national home infusion organization Evaluation of dabigatran use in hospitalized patients Impact of pharmacy technician‐centered medication reconciliation on optimization of antiretroviral therapy and opportunistic infection prophylaxis in hospitalized patients with HIV/AIDS Evaluation of pharmaceutical drug prescriptions in a public hospital in Brazil Cross‐sectional study examining the differences between US rural and non‐
rural adults in appropriate prescriptions for nitrofurantoin for the treatment of urinary tract infections (UTIs) in the ED Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Design and implementation of an antimicrobial stewardship program focusing on de‐escalation of antimicrobial therapy and intravenous to oral conversion at a Veterans Affairs Medical Center Evaluation of a pharamcist‐
led intervention to increase contraceptive counseling in women of childbearing age prescribed potential teratogens in a Family Medicine clinic Exploring the role of pharmacists in prevention of patient falls in a community hospital setting: a pilot project Evaluating the implementation of a pharmacist‐managed renal dose adjustment protocol Evaluation of appropriate parenteral nutrition utilization and the development of utilization guidelines Retrospective evaluation to determine screening adherence associated with amiodarone use Assessment of the attitudes of family medicine residents and faculty regarding pharmacotherapy education and interaction with pharmacists, pharmacy residents, and pharmacy students at a rural family medicine training program Evaluating the use of levofloxacin in urinary tract infections (UTI): a retrospective review and analysis 9‐258 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐172 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐016 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐098 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐026 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐246 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐314 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐003 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 315011 Katie Marie Simmons WV 317867 Amanda R Simpson PA 318385 Katie Sims AL 315951 Elizabeth Sizemore OR 315264 Sarah E. Slater MO 315657 Nicole Slater VA 315791 Jenna Sloan WY 316625 Allorie T Smith AK 121 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 315475 Michael Smith PA Evaluating the incidence and treatment of telaprevir‐
induced rash 6‐125 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316221 Jennifer Smith NC 7‐076 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317668 Ashley Smith OH 8‐140 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317715 Corey D Smith TX 8‐290 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316313 Mark A. Smith AL 9‐003 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316294 Jenifer Smith WA 9‐223 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316472 Carmen B. Smith WV 9‐264 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318402 Michael Smithson KY Weight‐based unfractionated heparin dosing nomogram for obese patients: efficacy and safety of dose caps for the treatment of venous thromboembolism (VTE) or acute coronary syndrome (ACS) Implementation of a multidisciplinary erythropoietin stimulating agent (ESA) protocol in a community hospital hemodialysis population: a focus on anemia management and education Effect of using ideal and adjusted body weight versus actual body weight in a weight‐based heparin protocol: a retrospective analysis Benefits of establishing a prediabetes clinic for patients at risk of developing type 2 diabetes Development of a quality metrics dashboard to evaluate ambulatory care pharmacy services at PeaceHealth Southwest Medical Center (PHSW) Evaluation of stress ulcer prophylaxis use in a medical and surgical intensive care unit of a public sector hospital in Port Elizabeth, South Africa Comparison of pharmacist directed interventions during the medication reconciliation process on accuracy and patient satisfaction at a community 10‐238 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 122 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time based hospital 315099 Breck Snoddy MO Standardized bowel regimen for patients on chronic opioids 7‐025 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318004 Brittany Rae Snodgrass OH 8‐152 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315802 Brandon Snyder PA 6‐132 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317030 Alydia Snyder TN 8‐210 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315250 Tiffany So PA Impact of Pharmacist Conducted Targeted Intervention Program (TIPS) Training across a Regional Chain Development and implementation of an alcohol withdrawal protocol in a community hospital Retrospective analysis of CHADS2 versus CHA2DS2‐
VASc risk stratification in patients admitted with acute ischemic stroke Efficacy and safety of warfarin therapy at Pennsylvania Hospital 6‐118 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316655 Chunkit So IN 9‐089 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 315937 Wonhee So FL 10‐071 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317804 Allison J Sok MI 8‐071 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317976 Angie Soken WA 9‐242 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 123 | P a g e Implementation of decentralized pharmacy practice model and electronic health record system in a community hospital Impact of pharmacists and an ID physician‐driven antimicrobial stewardship program in a 395‐bed, acute care, community hospital Analysis of smart pump implementation and drug library utilization in a pediatric hospital Analysis of outcomes after implementation of comprehensive drug therapy management services for employer‐based health insurance beneficiaries in a community non‐profit Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 6‐041 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐070 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐217 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐065 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐211 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐187 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐048 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐209 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. health system. 317997 Kangwon Song GA 316252 Dipal Soni NJ 317453 Laura Soriano 317251 Sarah Sougstad IA 317089 Nikki Sowards TN 316450 Adam Michael Spaulding NY 318448 Amy Elizabeth Speakman CA 317289 Katherine M Spence NY 124 | P a g e Spain Optimizing multimodal analgesia with intravenous acetaminophen and opioids in postoperative bariatric patients Impact of rapid diagnostic tests on vancomycin exposure in patients with blood cultures positive for gram‐positive cocci in clusters Safety of anti‐epidermical growth factor receptor (EGFR): erlotinib and gefitinib Implementation and continuous quality improvement of a pharmacy technician based medication historian program Retrospective analysis of stress ulcer prophylaxis prescribing patterns in the critical care and general medicine populations Evaluation of the use of intravenous acetaminophen among adult bariatric patients in a tertiary academic medical center An analysis of Contingent Therapy programming and its impact on prior authorization volume and necessity for clinical pharmacist review Impact of pharmacist intervention versus no pharmacist intervention on diabetes, dyslipidemia, and hypertension outcomes in a patient centered medical home Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 315873 Brian Spencer IN Expanding pharmacists role in inpatient services 9‐075 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316877 Lynne J. Spiegel NJ Assessment of Inpatient Glycemic Control in Non‐
Critical Care Setting 6‐077 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316381 Jonathan W Spry AL 9‐004 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317680 Matthew St.Amand WA 9‐236 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 315484 Lauren N. Stahley PA 6‐126 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316939 Abby L. Stahowiak MN 9‐177 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316025 Heather Stamper FL 10‐072 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317513 Kimberleigh Stan MA A continued quality improvement plan to increase the rate of barcode identified medication order scans Early postoperative multimodal analgesia and the role of parenteral acetaminophen. Incidence of hypoglycemia in patients undergoing therapeutic hypothermia for in‐hospital post‐cardiac arrest resuscitation Evaluating a community hospital's nomograms for intravenous heparin dosing using the activated partial thromboplastin time value Pharmacist's impact: monitoring and optimizing antibiotic selection in community‐acquired pneumonia patients Clinical decision support for antimicrobial stewardship 9‐140 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318154 Ekaterina Stanilova CT 10‐048 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316784 Sherri L Stark OK 7‐259 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316621 Andrew Starzinski WI 6‐271 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 125 | P a g e Medication use utilization evaluation of hydromorphone in a community teaching hospital Implementation of pharmacist‐led inpatient glycemic control and coordination of outpatient diabetes care Clinical pharmacy services and ambulatory internal medicine quality initiative: Submissi
on ID Primary Author Full Name State/ Country Title assessment of drug therapy recommendations, economic impact, and patient and provider satisfaction Analysis of the use of levetiracetam compared to phenytoin and fosphenytoin for seizure prevention in traumatic brain injury patients Impact of a daily inpatient congestive heart failure counseling service Session/ Board Number Day Time 9‐100 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐195 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐168 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐196 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐141 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐047 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐168 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318362 Bryan M Statz IN 316553 Rachel Staudt NY 314295 Darin Steenerson MN 317632 Chandra Steenhoek NV 316233 Jenise Stephen PA 316396 Scott A. Sterrett MI 317623 Alison Stetzler PA 318142 Sean Stevener ME Effects of a standardized questionnaire on evaluating beta‐lactam allergies 9‐162 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318160 Daniel R. Stevens PA Predictors of CTCAE grade 2 or greater hypersensitivity to equine anti‐thymocyte globulin (hATG) and utility of intradermal test dose 6‐185 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 126 | P a g e Cross‐sectional study using 2010 Behavioral Risk Factor Surveillance Survey data comparing differences in receipt of pneumonia vaccine by rural and non‐
rural US adults 18‐64 years with diabetes Fracture risk assessment tool comparison in male veterans Dabigatran etexilate mesylate and warfarin for atrial fibrillation: a medication‐use evaluation Opioid equivalency ratios when converting intravenous hydromorphone to oral morphine or oxycodone in adult cancer patients Evaluating pulmonary surfactant usage in a neonatal intensive care unit Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 8‐156 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐121 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐081 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐187 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐135 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐001 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐221 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐041 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. administration in patients with aplastic anemia 318079 Jessica Elaine Stevens OH 316645 Hilary Paige Stewart OH 316362 Erika M. Stiene NC 318235 Zachary R Stoecker MN 318426 Sylvia Stoffella FL 315522 Lowell Stone AL 316508 Rebekah Stover KY 316628 Katie E Stow MO 127 | P a g e Improving the Quality of Inpatient Oral Anticoagulation by Pharmacist Consultation and Management of Therapy Analysis of pharmacist‐
conducted telephonic medication reconciliation after patient discharge from hospital to home as an integral part of a transition of care (TOC) program Bivalirudin and unfractionated heparin use during low risk, elective percutaneous coronary intervention (PCI): a retrospective medication use evaluation Investigating the incidence of pneumonia in patients prescribed clozapine at a large, tertiary‐care hospital Outcomes of pharmacist‐
provided discharge medication counseling for patients with congestive heart failure Impact of pharmacist‐led medication reconciliation in a community pharmacy on all‐cause 30‐day hospital readmissions and emergency department visits Sotalol versus amiodarone in atrial arrhythmias: impact of renal insufficiency and ejection fraction Therapeutic Heparin Dosing Requirements in Obese Patients Versus Non‐Obese Patients Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day A multidisciplinary transitions of care program vs. standard of care in older patients after discharge from an academic medical center Improving pharmacy student readiness for advanced pharmacy practice (APPE) rotations and residency training by participation in an elective class Effectiveness of intravenous acetaminophen in post surgical patients at a community hospital Measuring the impact of peptide nucleic acid fluorescence in situ hybridization (PNA FISH) for identification of coagulase negative staphylococci on vancomycin use in bacteremic patients Impact of pharmacist discharge counseling for patients with sickle cell disease Using lean methodology to improve productivity and safety in a hospital oncology pharmacy Retrospective comparison of the incidence of acute kidney injury in patients treated with intravenous polymyxin b or intravenous colistimethate sodium Developing a competency‐
based training program for Proactive Panel Support (ProPS) pharmacists in an integrated health care system Evaluation of glycemic control in the non‐critically ill diabetic hospitalized patient in a Veterans Affairs 8‐028 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐189 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐110 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐242 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐027 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐040 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐155 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐106 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 6‐267 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 315422 Paul Stranges MI 318629 Ashley M Stull PA 318503 Jelena Stupar NC 318376 Christy Peggy Su NY 315266 Sayo Sudo MO 316962 Peter Sullivan CT 316996 Rebecca Sumner PA 318309 Monica Sung OR 316509 Travis Suss WI 128 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 6‐064 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐117 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐084 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐172 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐185 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐128 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐160 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐253 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. Medical Center 315381 Siddharth F. Swamy NJ 316481 Caitlin N Swann OH 316365 Whitney R. Sweatt IN 318530 Frank Matthew Szczerba OH 317988 Ryan Szynkarek IL 316402 Leo L Tabayoyong MA 315635 Eileen Tang NY 314204 Jill Tangeman OK 129 | P a g e Atypical haloperidol‐
associated neuroleptic malignant syndrome in a critically ill patient Limited fluoroquinolone resistant infections demonstrated after prostate biopsy Evaluating the appropriateness and cost effectiveness of epoetin alfa versus darbepoetin alfa in the treatment of chemotherapy‐induced anemia in an outpatient setting Pharmacist Involvement in Rapid Response Team Utilizing pharmacists to facilitate the medication reconciliation process through identification of medication discrepancies in a heart failure clinic Development of internal decentralized pharmacist productivity metrics to benchmark performance and staffing requirements Perioperative management of antithrombotic therapy in an acute care hospital: a retrospective evaluation Implementation of a standardized order set to evaluate dosing and monitoring of vancomycin in pediatric patients with methicillin‐resistant Staphylococcus aureus (MRSA) infection Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Analyzing the potential interaction of voriconazole and cyclophosphamide in pediatric patients receiving preparative regimen for stem cell transplant Response to The Joint Commission sentinel event alert regarding the safe use of opioids in the hospital setting Evaluating Post‐Stroke Depression in Order to Improve Functional Outcomes Healthcare practitioners knowledge and attitudes toward the use of Vaseline balls for the management of constipation in hospice and palliative care patients Retrospective evaluation of the treatment of febrile neutropenia in oncology patients at Lee Memorial Health System Evaluation of pharmacist management of dabigatran in an inpatient setting 8‐012 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐232 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐079 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐137 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐133 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐039 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 6‐143 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐272 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐157 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐091 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317872 Ammara Tanweer DC 317643 Holly Tate KY 316311 Evan Tatum NC 317646 Candice Tavares OH 318391 Stephanie Tears FL 315998 Kristen Tedders MI 316336 Adrienne Terico PA 317146 Brian Terrell TX 316332 Patrick Teune ME 317101 Ashley T Tewksbury IN 130 | P a g e De‐escalation of anti‐
methicillin resistant Staphylococcus aureus (MRSA) therapy for non‐
MRSA and culture negative pneumonia Early diagnosis of diabetes in the inpatient setting based on risk factor screening Time until therapeutic trough concentrations of tacrolimus in kidney transplant patients Concurrent use of oral paliperidone or risperidone among patients prescribed paliperidone palmitate long‐
acting injectable Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Impact of group education classes utilizing a conversation map in patients with type 2 diabetes mellitus Improving safe chemotherapy use by implementation of standard order forms at an academic medical center Evaluation of amiodarone monitoring compliance after implementation of a clinical reminder Comparison of pharmacy student‐led versus nurse‐led medication reconciliation initiation at a large regional medical center Infliximab Use at NewYork‐
Presbyterian Hospital: A Retrospective Medication Use Evaluation Medication reconciliation and telecommunication: a collaborative approach to improve healthcare outcomes in hospitalized patients with heart failure Bleeding risk associated with antiplatelet therapy in chronic kidney disease patients following acute coronary syndrome. Impact of pharmacy interventions on pneumonia 30 day readmission rates 8‐167 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐131 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐091 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐159 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐154 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 10‐225 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐134 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐189 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐243 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐262 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318311 Kristen M Thatcher OH 316725 Michelle Then MA 316934 Michael Thiman NC 316232 Caitlynn Thomack IL 314618 Christan M Thomas NY 316847 Mary Thomas KY 317279 Erin L. Thompson OH 318518 Linsey L. Thompson MN 315811 Rachel Guillory Thompson LA 316257 J. Douglas Thornton WV 131 | P a g e Impact of implementing a nurse driven protocol on adult pneumococcal vaccination rates Effect of an electronic order clarification system on timely patient care Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Survey of performance for extended‐infusion dosing (SPEID) of piperacillin/tazobactam in a community hospital Analysis of clinical pharmacist impact on low density lipoprotein cholesterol values in cardiovascular disease patients through a live, primary care‐based intervention program Monotherapy versus double‐coverage of Pseudomonas aeruginosa: a combination antibiogram for hospitalized veterans Prevalence of potentially inappropriate drug‐disease interactions in a Veterans Affairs Community Living Center using two methods Implementation of standard concentration intermittent IV medication therapy in a pediatric patient population: impact on patient safety. Comparison of intraoperative injections for sustained analgesia after total knee arthroplasty Retrospective analysis of standard versus optimized dosing of piperacillin/tazobactam and cefepime in obese patients with gram‐negative severe sepsis or septic shock due to pneumonia Outcomes associated with prothrombin complex concentrate for international normalized ratio reversal in patients on oral anticoagulants with acute bleeding 10‐239 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐139 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐243 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐069 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐154 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐092 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐270 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐063 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318447 Nicholas Thrasher KY 317358 Ricky Thumar MA 315403 Lindsay Thurman TX 315933 Kelsey A. Tiemann NC 318018 Kristin Tien OH 318232 Teya Tietje MT 317110 Loc Tieu TX 314157 Ryan D. Tilton NC 132 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Rate of readmission in patients with post‐operative atrial fibrillation after cardiothoracic surgery Care transitions service: description of a pharmacy‐
driven medication reconciliation program through the continuum of care. Healthcare failure mode and effect analysis (HFMEA) of the home health care process at the Cincinnati veterans affairs medical center Effect of a pharmacist‐led monitoring service on antiretroviral medication errors Human immunodeficiency virus (HIV) medication adherence barriers in Ilula, Tanzania: piloting a global health rotation for a post‐
graduate year one (PGY1) pharmacy residency Effectiveness of switching virologically suppressed HIV‐
infected patients from emtricitabine and emtricitabine‐containing products to lamivudine Cost‐benefit analysis of employing a second infusion pharmacist for medication therapy management (MTM) Development and Implementation in Facilitating the Utilization of Community Hospital Pharmacist for Medication Therapy Management for Employees of a Self‐Insured Hospital 8‐062 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 7‐128 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐108 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐085 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐175 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐287 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐041 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐105 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317334 Long To MI 316491 John C. Togami NM 316020 Brittany A. Tomlin OH 316409 Charles R. Tomlin IN 316095 Jessica E Tonder MN 317465 Emily K. Tong TX 316825 Lena Ton‐nu CA 317162 Thomas Towers FL 133 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 317879 Jennifer L Towle NH Alert fatigue: An analysis of medication alerts seen by pharmacists 6‐061 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318525 Anh P Tran MD Evaluating the effect of hypoalbuminemia on vancomycin dosing 7‐023 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315027 Van L Tran DC 8‐001 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315310 Linda Tran OH 8‐100 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318216 Linh Tran TN 8‐223 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317018 Thuytram Tran TX 8‐267 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 315428 Tu T Tran CA 9‐027 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317964 Bao Anh C Tran FL 10‐119 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316564 Christine M Trask WA Evaluating the use of sodium acetate compared to sodium chloride in central venous access management in neonates Impact of a patient aligned care team (PACT) model pharmacist in a rural community based outpatient clinic (CBOC) Evaluation of pharmacist intervention on the initiation of diabetes treatment in heart surgery patients with undiagnosed diabetes and hemoglobin A1C greater than 6.5 percent. Risk factors for methicillin‐
resistant Staphylococcus aureus pneumonia on hospital admission in healthcare‐associated pneumonia patients Development and implementation of a pharmacist run diabetes clinic protocol Evaluating the Impact of Expanding Pharmacy Services in the Emergency Department: A Retrospective Patient Chart Review of Pharmacy Recommendation/Interventi
ons on Antibiotic Utilization in the ED Improvement in Clinical Pharmacist Services and Associated Cost Savings in the Inpatient Psychiatric 9‐225 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 134 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time Unit 318118 Laura M Trembath FL Evaluating total parenteral nutrition (TPN) use and variability 10‐124 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317978 Zachary Tressel OH 8‐149 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316839 Angel Trieu TX 8‐264 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316399 Amanda L Troup MO 7‐036 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317099 Laura M Truhlar NH Using MRSA active surveillance cultures as evidence to de‐escalate antibiotic therapy Time‐focused highly active antiretroviral therapy (HAART) initiation in HIV naive patients Evaluating the influence of intravenous acetaminophen on narcotic use in hip fracture surgical patients Outpatient prescribing habits of nitrofurantoin in the geriatric population 6‐058 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 315812 Cherry Truong NJ 6‐067 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318312 Katherine Winlin Tsai TX 8‐298 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316344 Karina Tselenchuk NY 7‐182 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315021 Andrew S Tsiattalos PA 6‐115 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 135 | P a g e Pharmacy initiated venous thromboembolism (VTE) prevention screening and treatment protocol in a 300‐
bed community hospital Implementing an ongoing interdisciplinary continuing education seminar at a community charity health center through collaboration with a College of Pharmacy Development of a look alike sound alike and high alert medication tracer program at an urban teaching hospital Effect of organic nitrates and hydralazine on wave reflections and left ventricular structure and function in heart failure with preserved ejection fraction Submissi
on ID Primary Author Full Name State/ Country Title Day Time 9‐254 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐073 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐156 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐010 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐188 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐259 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐251 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐010 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318615 Crystal Tsui WA 318015 Rhianna Tuchscherer MI 318320 Sunita Tufekcic MA 316787 Patrick R. Tully AZ 314086 J. Benton Turner TN 315029 R. Brigg Turner WV 317544 Katherine Tweedy‐Li VA 316700 Jared Underdahl CO 315974 Alekhya Uppala NJ Impact of education on the timing of vancomycin trough levels 6‐068 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 318517 Ann Upshaw AZ Evaluation of levetiracetam within a 369‐bed community hospital 6‐016 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 136 | P a g e Impact of pharmacy intervention on medication safety processes within the perioperative environment Evaluation of alvimopan utilization within a large, tertiary health‐system Session/ Board Number Evaluation of pharmacist‐
managed pneumococcal vaccination program for adult inpatient population at a community hospital Effects of implementing an antimicrobial stewardship program (ASP) on antibiotic use, prescribing, and cost in an adult care unit of a Native American community hospital Impact of the PALLAS trial on the appropriateness of dronedarone use at a community teaching hospital Treatment of vancomycin‐
resistant Enterococci (VRE) isolated from urinary samples Compliance to American Diabetes Associate (ADA) position statement recommendations in medical inpatients at Inova Fairfax Hospital Decreasing the treatment of asymptomatic bacteriuria in inpatients Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Efficacy of high dose unboosted atazanavir in combination with emtricitabine/tenofovir in HIV infected patients RISK FACTORS ASSOCIATED WITH TIME‐TO‐
READMISSION IN VETERANS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER AT THE VAWNY HEALTHCARE SYSTEM Clinical utility of rectal swabs as a predictor of vancomycin‐resistant enterococcal infections requiring antibiotic treatment Empiric antibiotic treatment utilization subsequent to aspiration event 10‐224 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐240 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐129 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐093 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐279 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐210 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐180 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐082 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐186 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316743 Lindsay Urben KY 318274 Brandon Utter NY 316423 Niyati Vakil MA 316653 Jose Valdes FL 317459 Amy Van Ermen WI 317017 Joel Van Heukelom SD 318047 Katelin Van Leer PA 316408 Adam Vanderman NC 316419 Binil Thomas Varghese NY 137 | P a g e Retrospective analysis of adherence to a sepsis protocol in the intensive care unit Nursing satisfaction of a nursing driven delirium assessment utilizing prompts while completing the confusion assessment method ICU (CAM‐ICU) Retrospective evaluation of admissions for chemotherapy‐induced nausea, vomiting, and dehydration Inhaler misuse in an older adult population Assessing the impact of a pharmacist‐led patient education program on hemodialysis patients using phosphate binders Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 317230 Christine M. Vartan FL Implementation of a pilot interdisciplinary pain rehabilitation program 10‐107 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317422 Hitesh D Vasnani NC 7‐094 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318474 Vanessa Vaupel NV 9‐202 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 318173 Allison Veire MN Design and implementation of clinical decision support tools within a newly acquired computerized order entry system in a community hospital setting Regional erythropoietin stimulating agent performance measure dashboard tool: Implementation and impact within the Veterans Affairs Sierra Pacific Network (VISN 21) Investigation of the bleeding risk and usage profile of ticagrelor 9‐185 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317634 Jineane Venci NY 7‐218 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315254 Sarah Verbyla PA 6‐119 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316150 Veronica P. Vernon IN 9‐077 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316515 Michael Vertin TN 8‐205 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316970 Noelia Vicente Oliveros Spain 6‐208 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 315961 Ruben David Villanueva 10‐003 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 138 | P a g e CO Impact of a pharmacist‐
initiated multi‐disciplinary oral cancer therapy program: results of a pilot In search of a tasteful approach to managing food‐
drug allergies in an academic health‐system Assessment of pharmacist managed smoking cessation versus usual care in a veterans affairs medical center Medication use evaluation of levalbuterol (Xopenex) in the adult population of a tertiary medical center. Discrepancies between pharmacist interview and medication data collected at the emergency department Comparison of different physician order‐sets for the management of acute alcohol withdrawal in a tertiary community hospital Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Evaluation of intravenous acetaminophen for pain management in bariatric surgery patients Effect of pharmacist educational counseling on medication adherence in elderly heart failure patients prior to hospital discharge Evaluation of the current prescribing practices of proton pump inhibitors in hospitalized patients. Frequency of antiretroviral related problems among hospitalized patients with HIV Evaluation of the potential use of hydroxyethyl starch 130/0.4 in an urban teaching hospital Tech‐check‐tech: a study of efficiency 9‐094 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐210 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐051 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 6‐033 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐189 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐099 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 10‐174 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐195 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐080 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐125 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐108 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317319 Sergio Villicana IN 317296 Celeste M. Vinluan NY 317615 Carissa Virtue MO 316603 Teresa Vo GA 318115 Andrew Volk IL 315960 April Von Allmen OR 317138 Ami Vora IL 318329 Johnathan Voss IL 318209 Ngoc Hong Vu MI 318121 Dat Vuong FL 316574 Jennifer Wade KS 139 | P a g e Utilizing lean six sigma methodology in implementation of a misoprotol protocosl for labor induction Outcomes of kidney donors receiving ketorolac versus non‐ketorolac based pain regimens Validation of a high dose vancomycin nomogram and risk factor analysis of supratherapeutic concentrations and nephrotoxicity Assessing the impact of a pharmacist‐led congestive heart failure (CHF) clinic on 30 day readmission rates Simulated Y‐site compatibility of vancomycin and piperacillin‐tazobactam Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 315745 Heather L. Walczyk FL Relationship between medication package inserts and 2012 Beers Criteria 10‐068 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317111 Mike Waldt OH A(3): reduction in I.V. drug waste 8‐131 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316583 Cucnhat P. Walker NE 7‐122 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316967 Claire Walter MI 8‐053 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316879 Enshih Wang NJ 6‐078 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316340 Steven Wang NY Investigating health literacy and medication adherence of cancer patients who are taking oral chemo‐
medications in the outpatient setting Effectiveness of a post‐
discharge email education program for acute myocardial infarction patients Evaluation of pharmacist intervention on piperacillin‐
tazobactam utilization in culture negative patients Evaluation of meperidine usage in the inpatient hospital setting 7‐181 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318648 Johnny V. Wang CA 9‐056 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 315404 Lisa Whui Wang NV 9‐194 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 315954 Jennifer Wang WA 9‐219 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316192 Carmen E Ward FL 10‐076 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 140 | P a g e Implementation of a restructured clinical pharmacy practice model in a community hospital Evaluation of an intervention to reduce proton pump inhibitor use at the VA Southern Nevada Healthcare System (VASNHS) Development of an interactive survey on employee attitudes of employer‐sponsored health wellness programs Measuring the impact of a medication surveillance system on antimicrobial de‐
escalation in a community hospital setting Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Appropriate usage of divalproex sodium formulations in a 445‐bed hospital Implementation of a pharmacist‐run clinic for chronic pain management at an Indian Health Service facility Impact of a pharmacist‐
managed ambulatory heart failure clinic to improve patient outcomes and decrease hospital readmission rates in an urban 228 bed Midwestern hospital Impact of a pharmacy based intravenous to oral antimicrobial conversion protocol as part of an antimicrobial stewardship program Implementation and evaluation of a unit‐based decentralized pharmacy staffing model The Effects of Pharmacists in a Multidisciplinary Team to Reduce 30 Day Heart Failure Readmission Rates Within A Large Community Hospital System Effects of prescriber education on methylprednisolone dosing in chronic obstructive pulmonary disease and asthma exacerbations Implementation of pharmacy medication therapy management (MTM) services in the patient aligned care team (PACT) model and the impact on diabetes 6‐253 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐126 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐064 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐252 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐209 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐019 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐009 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 9‐059 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317707 Ginger Warren VA 315671 Keith Warshany NM 317150 Andrew Washburn IA 312724 Sarah C. Watkins OK 316871 Jeff J. Watkins TN 318591 ShaRhonda M Watkins AL 317135 Melissa G Weaver MD 315395 Elizabeth Webb 141 | P a g e IA Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 317116 Andrew Wechter MI 8‐056 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318522 Rebecca A. Wedow NY 7‐248 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 312719 Karen Weigand MI 8‐023 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316322 Aaron J. Weigelt CA 9‐031 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 315480 Sam Weitzel TN 8‐195 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316676 Melanie A West KY 10‐223 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315172 Christopher J. Westerfield KY 10‐203 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 318019 Elise B. Weyrauch OH 8‐155 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317717 James S Wheeler TN Evaluation of current aminoglycoside pharmacist dosing practices at a community teaching hospital Use of high‐risk medication for treatment of hyperkalemia: an evaluation of intravenous insulin use in hospitalized patients Medication use evaluation of phytonadione (vitamin K) in patients admitted to a large, private academic institution Design, implementation, and monitoring of a pharmacist‐run medication reconciliation and discharge counseling program at a multicenter health‐system. Economic effect of long‐
acting depot antipsychotic utilization on adult readmission rates in an inpatient setting Comparison of a critical care versus non‐critical care intravenous insulin infusion protocol in a community hospital intensive care unit Pharmacist medication access counseling in patients with chronic obstructive pulmonary disease Evaluation of the reliability of point‐of‐care international normalized ratio data in a trauma bay Impact of pharmacist provided disease state and inhaler device education on patient satisfaction in patients with chronic obstructive pulmonary disease (COPD) 8‐216 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 142 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Development and implementation of an education class for patients with hypertension Conversion from activated partial thromboplastin time (aPTT) to antifactor Xa levels for monitoring of unfractionated heparin infusions Effect of antibiotic selection on incidence of 30 day post‐ discharge emergency department visits and readmissions due to acute exacerbation of chronic obstructive pulmonary disease Initiative to reduce 30‐day hospital readmissions in patients admitted to a community hospital Implementation of a venous thromboembolism prophylaxis protocol at the VA Maine Healthcare System Comparison of the confusion assessment method in the intensive care unit (CAM‐ICU) and the intensive care delirium screening checklist (ICDSC) in identifying clinically relevant outcomes in critically ill patients. Heart failure patients evaluated in pharmacist managed clinics and resulting clinical outcomes (HERO) Evaluation of risk of Clostridium difficile infection with gastric acid suppressive therapy in trauma patients What is the role of an ambulatory care pharmacist conducting medication reconciliation during a 6‐050 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 7‐265 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 8‐202 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐224 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 9‐160 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐015 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 8‐233 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐207 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 7‐272 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 314507 Emily White MS 317818 Tiffany Noel White OK 316453 Cyle White TN 318280 Brittany N. White TN 317888 Cassandra White ME 318267 Shawn Whitehead CO 312616 Christine Ann Wicke TX 315430 Jennifer A. Wiedmar KY 318193 Avery James Wight OK 143 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 8‐308 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐198 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐070 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 10‐115 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐257 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 8‐069 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 8‐087 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. hospital discharge follow‐up visit? 318538 Casey J. Wilbert TX 315641 Cole Wilder TN 315935 Amy Elizabeth Wilds FL 317684 Brandon Wilds FL 315009 Ashley Nicole Wilhelm WV 317598 J. Bradley Williams MI 318532 Donnell Lamar Williams MI 144 | P a g e Retrospective evaluation of an antimicrobial stewardship treatment pathway for the management of cystitis and acute uncomplicated pyelonephritis in an emergency department setting Retrospective evaluation of factors contributing to Clostridium difficile infections in a community teaching hospital Bleeding incidence with dialysis patients on treatment doses of enoxaparin Capping single dose IV ondansetron at 16 mg from 32 mg and its effect in moderate and highly emetogenic chemotherapy regimens Design and implementation of an antimicrobial stewardship program focusing on pharmacokinetic dosing and renal monitoring at a Veterans Affairs Medical Center Association between liver disease and QTc prolongation following antipsychotic treatment in critically ill patients Efficacy of dual atypical antipsychotic therapy: a retrospective review analysing if combination therapy reduces hospitalizations and time to readmission in veterans with schizophrenia Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 318102 Chelsea Williams IL 10‐188 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317875 Rachel A. Williams LA 10‐247 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315158 Riley Williams II FL 10‐060 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316478 Steve Willis DC 8‐005 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317992 Liza Wilson MS 6‐053 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316815 Valerie S. Wilson OK 7‐261 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 315375 Natalie Wilson TX 8‐241 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316226 Bruce Winchester OK Pharmacist education to improve discharge counseling in patients admitted with heart failure Parental compliance with prescribed outpatient antibiotic therapy for treatment of osteomyelitis and septic arthritis in a pediatric, Medicaid population Impact of a standardized medication reconciliation form and a bring your medicines campaign on medication discrepancies in an indigent ambulatory care setting Incidence of invasive fungal infections in pediatric leukemia patients on fluconazole prophylaxis Evaluation of the implementation of Million Hearts Team Up. Pressure Down. patient adherence model in chain vs. independent community pharmacy settings Implementation of an antimicrobial stewardship program in a rural medical/surgical care unit Evaluation of sedation and analgesia use in critically ill patients receiving neuromuscular blocking agents State regulations and perceptions related to pharmacy practice evolution 7‐258 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317613 Bryce Winn WA 9‐234 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 145 | P a g e Analysis of Total Parenteral Nutrition (TPN) usage in a large tertiary hospital and implementation of a pharmacist prescriptive authority protocol to dose and adjust TPN. Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 314473 Sarah Elizabeth Wisecup TX Thromboprophylaxis in the pediatric population: how compliant are we? 8‐236 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316770 Robert Witcher NY Sedation practices in the neurosciences intensive care unit 7‐201 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316035 Kirsten Woelfel NY 7‐172 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317860 Amy Wojciechowski NY 7‐226 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316023 Danielle Wojtaszek CT 10‐023 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 316452 Matthew Wolf MO 7‐037 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318483 Marissa L Wolff CT 10‐051 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317915 Jared Wonders OH Prevalence of colonization and antimicrobial resistance in catheterized spinal cord injury outpatients undergoing urodynamic evaluation Incidence of Clostridium difficile after treatment with antibiotics for a chronic obstructive pulmonary disease (COPD) exacerbation
Anticoagulation‐related hospital readmission rates for patients of a pharmacist‐
managed anticoagulation clinic Development of a prioritization tool for a Clinical Decision Support (CDS) build within a Computerized Physician Order Entry (CPOE) system Comparison of time in therapeutic range between telephone and point‐of‐care methodologies in a VA Anticoagulation Clinic Retrospective review of dyslipidemia outcomes in clinical video telehealth 8‐145 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 317998 Ryan K Wong VA 6‐254 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317868 Rebecca L. Wong NM 7‐137 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 146 | P a g e Comparison of efficiency of computerized prescriber order entry (CPOE) to traditional pharmacist order processing in a community hospital Implementation and evaluation of 30 day supply dispensing in a rural pharmacy Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 315582 Doris Wong NY Evaluating warfarin adverse drug events leading to hospital admissions 7‐158 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316414 Milena Grace Wong NY 7‐185 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316696 Jane J Wong NY 7‐200 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317274 Richard Chen Wong TX 8‐277 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316620 Sunghye M. Woo PA 6‐148 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316251 Mallary Wood OH 8‐111 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 312955 Robert C. Wood III TN 8‐187 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 312106 Erin Woodard TN Evaluation of a medication use process for safe utilization of look alike sound alike and high alert medications using a tracer methodology Retrospective, computerized evaluation of metronidazole or vancomycin monotherapy versus combination therapy in Clostridium difficile infection Comparison of hospital readmissions and mortality between statin and non statin users in acute exacerbations of diastolic heart failure Assessment of continuous sedation versus intermittent sedation (ACSIS) in mechanically ventilated patients: a prospective, cohort study Evaluation of dornase alfa use in intensive care unit (ICU) patients without cystic fibrosis at a free‐standing children's hospital Psychiatric outcomes associated with citalopram dose reduction in Veterans after Food and Drug Administration warning: a retrospective follow‐up study Assessing the Appropriate Use of Levofloxacin in Outpatient Treatment of Urinary Tract Infections at a Veterans Affairs Medical Center 8‐185 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 147 | P a g e Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Empiric gram negative antimicrobial therapy optimization as part of an antimicrobial stewardship program utilizing a unit‐
based antibiogram in an acute care community teaching hospital Impact of a pharmacist‐
directed intervention on achieving primary and secondary cholesterol goals in patients with high triglycerides Outcomes using alternative meropenem dosing strategy in the critically ill 10‐117 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 6‐248 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 8‐245 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. Implementation of a learning module that educates and credentials medical residents and staff to write PCA orders in the pediatric population Impact of Medication Therapy Management program for patients with dyslipidemia in a hospital‐
based outpatient primary care clinic Integration of the Nanosphere Verigene test for rapid recognition of Gram‐positive bacteria and resistance factors into an antimicrobial stewardship program The Effects of Proton Pump Inhibitors and Histamine 2 Blockers on the Incidence of Clostridium Difficile Infections in a Community Hospital Medication use evaluation of inhalational anesthetics 8‐313 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 10‐044 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐097 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 7‐007 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 7‐178 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 317859 Marylee Worley FL 316166 Evan Bradley Wright VA 315542 Michael E. Wright TX 316253 Chanin Wright TX 317956 Jessica Wright CT 317900 Justin E. Wrin IN 316832 Ivy Wu MD 316231 Tammy Wu NY 148 | P a g e Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Time 316291 Diana Wu OH Effect of pyridoxine on levetiracetam‐associated behavioral changes 8‐113 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316214 Nick Wytiaz PA 6‐139 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316519 Anna Yakumithis OH 8‐118 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318297 Serena Yang MD 7‐018 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 318584 Alice Yang TX 8‐310 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 316953 Daniel M Yarabinec PA 6‐154 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316446 Deniz B Yavas FL 10‐087 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315613 Kevin Yeh MA 9‐124 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 316595 Juwon Yim FL 10‐090 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317003 Borrego‐
Izquierdo Yolanda Spain 6‐210 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 317221 Jessica Yoo Evaluation of venous thromboembolic prophylaxis noncompliance in a tertiary medical center Development and implementation of a delirium management program Impact of first fill counseling on medication events in patients with a history of hospitalizations for heart failure Discharge counseling to decrease medication non‐
adherence and hospital re‐
admission rate Management and impact of bleeding complications with dabigatran, rivaroxaban, and warfarin Review of the appropriate use of colchicine after the implementation of a prescribing template in a Veterans Affairs Healthcare System (VAHCS) Retrospective Analysis of Boceprevir Therapy for Chronic Hepatitis C Virus (HCV) Infection: A Pilot Study Retrospective analysis of meropenem utilization patterns in a pediatric hospital Comedication influence on the risk of clinically relevant drug interactions in the HIV patients Evaluation of bleeding risk prediction scores for parenteral anticoagulants used for VTE treatment at a university health system 8‐060 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 149 | P a g e MI Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day 316892 Mikinori Yoshida Japan 6‐048 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 316575 Mandy L. Young AR 9‐020 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317510 William Yu NY 7‐214 Wednesday, December 5 10:00 a.m. ‐ 11:00 a.m. 316945 Jenny Yu CA 9‐042 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 315565 Gregory E Yugov PA 6‐130 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 315256 Carrie L. Zechmeister MI Evaluation of aprepitant as prophylactic antiemetics of cisplatin split regimen or low dose weekly cisplatin regimen combination with radiation Effect upon patient satisfaction with pharmacist intervention at time of admission and discharge Using a multidisciplinary approach to optimize smart pump technology to promote medication safety in adult oncology patients Evaluation of the transitional care pharmacist (TCP) program on reduction of hospital 30 day readmission rates in high risk patients Impact of a telephone intervention for hypertensive patients on blood pressure and treatment adherence Continuation of statin therapy in patients with sepsis 8‐024 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 318014 Daphne Zeilinger FL 10‐120 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 315369 Keri Zeiser CO 10‐002 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 317439 Sonya Zhan MI 8‐067 Wednesday, December 5 11:30 a.m. ‐ 12:30 p.m. 150 | P a g e Reducing vancomycin failures through an implementation of an antimicrobial stewardship program pharmacist‐driven vancomycin protocol in a community based teaching hospital Evaluation of procalcitonin‐
guided antibiotic therapy in septic and septic shock patients at a tertiary community hospital Determining the optimal creatinine clearance dosing weight for vancomycin in the overweight and obese population using an online medical calculator Time Submissi
on ID Primary Author Full Name State/ Country Title Session/ Board Number Day Efficacy of an oral vancomycin loading dose in patients with confirmed clostrium difficile infection Comparison of the rate and severity of hypoglycemic events in surgical intensive care unit patients on intensive versus modified conventional insulin therapy: a pilot study Integrating pharmacy involvement in the discharge and follow‐up process for congestive heart failure (CHF) patients at a regional health center Impact of a diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome mandatory treatment protocol on the frequency of electrolyte monitoring in emergency department Evaluation of outpatient urinary tract infection management following implementation of electronic order sets within the VA Maine Healthcare System Evaluating and improving the use of non‐intravenous antibiotics in the operating room: a single center review. Social media use, opinions, and education among South Dakota pharmacists 10‐041 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐122 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 9‐111 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 10‐033 Wednesday, December 5 2:30 p.m. ‐ 3:30 p.m. 9‐161 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 6‐275 Wednesday, December 5 8:30 a.m. ‐ 9:30 a.m. 9‐205 Wednesday, December 5 1:00 p.m. ‐ 2:00 p.m. 317085 Min Zhang CT 311800 Winnie Zhu MA 317021 Christopher Zielenski KS 316547 Katarzyna M Zlotnik CT 318067 Peter Zolas ME 317043 Gregory M. Zumach WI 315400 Andrew Zwack SD 151 | P a g e Time